Annual Report 23-9-13

2012 - 20139th Annual Report

INDIAN GATEWAY TO GLOBAL PHARMA EXPORTS

phar exm cil

Pharmaceuticals Export Promotion Council of India(Setup by Ministry of Commerce & Industry, Govt. of India)

India Pavilion at AFRICA HEALTH, Johannesburg, South Africa - 9-11th May 2012

US FDA Workshop on Generic Drug Applications – 2nd May 2012, Hyderabad

India Pavilion at AFRICA HEALTH, Johannesburg, South Africa - 9-11th May 2012

7th NUTRA INDIA SUMMIT, Bangalore - 15-17th March 2012


India Pavilion and Pharma Brand India Campaign at CPhI-SEA Indonesia 10-12th May 2012

India Pavilion at VitaFoods, Geneva, Switzerland - 22-24th May 2012

India Pavilion at VitaFoods, Geneva, Switzerland - 22-24th May 2012

9th Annual Report 2012-2013 01

CONTENTS OF ANNUAL REPORT 2012-13

Sl. No. Subject

1 Notice for the Meeting

2 Performance of Indian Pharma Industry

3 Membership

4 Committee of Administration

5 Export Promotional Activities

6 Accounts for 2012-13

7 Circulars Issued

8 Trade Enquiries issued

9 Export Award Winners

10 Patent Award Winners

11 Beneficiaries under MAI Scheme

12 Beneficiaries under MDA scheme

Annexure No.


Ref: PXL/H.O./CIR-055/2013-14 Date: 06.09.2013

ToMember, COA, PHARMEXCIL,

Dear Sir/Madam,

Notice is hereby given for 9th Annual General Meeting of the Council to be held on Thursday, 25th September, 2013 (2.30 -3.30 P.M.) at Hotel Marriott, "Saphire Ball Room" Tank Bund Road, Hyderabad to transact the following:

1. To consider and approve the minutes of the 8th Annual General Meeting held on 27.09.2012 at Hyderabad.

2. To consider the report on the activities of the Council for the year 2012-13

3. To consider and approve the report of the Auditors and the Annual General accounts of the Association for the year ended 31st March, 2013.

4. To appoint auditors for the year 2013-14.

5. To consider any other matter with the permission of the Chair.

All members are requested to make it convenient to attend the meeting.

Thanking you,

Raghuveer KiniExecutive Director

Note: Subsequent to Postponement of RBSM, CEO conclave etc., Venue and time for AGM have been changed to Hotel Taj Deccan at 5.30 PM respectively.

N O T I C E

A G E N D A


INDIAN PHARMACEUTICAL INDUSTRY IN 2012-13 – AN OVERVIEW

1. Pharmaceutical Exports of India

Drugs, Pharmaceuticals and fine chemicals have been Fifth largest exported principal commodity of the country accounting for 4.83% of India’s total exports. In line with last two decades India’s pharmaceutical industry, has achieved a positive trade balance and the initial estimates puts it around USD 8.75 to 9.0 billion.

As per the latest Periodic statistics released by Director General of Commercial Intelligence & Statistics (DGAFRICA), Kolkata, India’s Exports of Drugs, Pharmaceuticals & fine chemicals for the period Apr. 2012 to March 2013 stood at INR 79,410* crore recording a growth rate 25% over the corresponding period of previous year. Exports have grown by a CAGR of 18.39% over the period 2008-09 to 2012-13.

*Figures provided are provisional & are likely to Change.


During 2012-13 India’s exports of finished dosage forms is likely to be in the region of 64%, bulk drugs in the region of 34.8 and herbals 1.2%. Finished dosage forms contribution is on the increase which indicates increased recognition of India’s pharmaceuticals world over.

The top 25 destinations of India’s pharmaceutical exports with values are given below. USA remains the top export destination with a share of 24.6% amounting to 20,239 crore and a growth of 29%. Among the top 25 export destinations exports to Russia, South Africa, Brazil, Ghana, Japan & Iran have shown remarkable growth with over 30%, with growth in Exports to Iran topping the list with 81%. Among the other major export destinations, exports to Nigeria, Canada, Kenya, Netherlands, Vietnam, Turkey, Australia, Singapore, Ukraine & Belgium have grown over 20%.


2. India In global arena:

To-day India’s pharmaceutical industry is known “Global pharmacy of the world”. India offers almost every product which has gone off patent and with a large vendor base. India’s filings of DMF’s with USFDA as of march 2013 is 3000, the highest filed by any country in the world. The below table gives complete tally of accreditations India’s exporters have received from various countries regulating authorities.

3. Opportunities for Growth

In spite of considerable achievements, several untapped business segments and markets exist and the room to enhance the country’s pharmaceutical exports is vast. The sophisticated chemistry capabilities, lateral thinking abilities in developing non-infringing processes, disciplined approach to adhere to any stringent guidelines, dedication for manufacturing excellence, etc., make India as a most favorites destination to source or outsource various components of value chain. In addition, despite our success, we are still at the periphery of this vast opportunity.


According To IMS calculations Global spending on medicine will reach USD 1100 billion by 2015,

at a growth rate of 3-6% from now on, which in fact is slower when compared to the growth rate

between 2005 and 2010 which was over 6%. Since number of efforts are being made all over

the globe to use the money spent on Health expenditure more efficiently, the focus on generics

seem to rise as it help stretches every Dollar spent longer. US share of global spending on

medicines which is now 41% is estimated to come down to 35%, while spending of high growth

17 markets led by China is likely to go up. The significant change in composition of spending

globally would be that 39 to 40% would be on generics instead of present 27%.

India as of now is poised well to take on those opportunities with their chemistry skills and the

best regulatory accreditations and the largest no of Market authorizations a single country can

ever have. The generic market is expected to touch USD 400 billion by 2015 and 70% of it is

expected to be spent in the countries of other than developed. India in the year 2009-10 has

exported 70% of its total to these markets.

A number of leading drugs go off patent every year and the generic pharmaceuticals

penetration is increasing in all the countries of the world further raising the opportunity for

exports in this segment. In 2011 USD 30bn worth of products went off patent. In USA alone

these products (mostly lipid lowering agents) are commanding a market of USD 17 billion with

93 million prescriptions. By generic market estimation the size may get reduced to USD 3bn

approximately. That is an extra USD 3 billion market opportunity opening up for generic

manufacturers. In fact the Pharmaceutical industry is now on the verge of reaching a patent

cliff. Intense science, good understanding of patents and manufacturing to the stringent

requirements of access regime, are key requirements for future success in this opportunity.

India has the requisite capabilities. Hitherto most opportunities emanated from synthetic

chemistry. The opportunities in biopharmaceuticals will be the major attraction in the next

decade. New technologies and enhanced regulatory requirements are changing the rules of

the game making production migrate to east.


State wise Registered Companies up to the Financial year 2012-13

State No. of Regd. Companies

Andhra Pradesh 520

Assam 1

Bihar 8

Chandigarh 37

Chattisgarh 2

Delhi 348

Goa 12

Gujarat 568

Haryana 86

Himachal Pradesh 21

Jammu 6

Karnataka 154

Kerala 41

Madhya Pradesh 71

Maharashtra 1621

Orissa 4

Punjab 48

Rajasthan 34

Tamil Nadu 238

Uttar Pradesh 80

Uttaranchal 23

West Bengal 53

Grand Total 3976


Category Wise Registered Companies

Category No. of Members

LSM 337

SSM 1662

ME 1977

Grand Total 3976

Panel Wise-Registered Companies

Panel Description of Panel No. of Wise Members

Panel-1 Pharmaceutical Formulations (Including Nutraceuticals, 879Excipients, Surgicals and Diagnostics, Veterinary Products etc)

Panel-2 Bulk Drugs & Drug Intermediates 652

Panel-3 Herbal Products (Including Ayurvedic, Homeopathic, 238Unani & Siddha Medicines)

Panel-4 Biotech Products 26

Panel-5 Pharmaceutical Services (Including R & D, 56Clinical Trials, Medical Transcripts)

Panel-6 Healthcare Services 56

Panel-7 Merchant Exporters (Traders, CROs) 1931

Panel-8 More Than One Panel 138

Total 3976


Elected Members

Government Nominees

Committee of Administration

Sri N R MunjalChairman

(Vice Chairman Ind-Swift Laboratories Ltd)

Sri Ashutosh GuptaVice Chairman

(Executive Director Medicamen Biotech Ltd)

Shri Paresh Chawla

Director

Alpa Laboratories Ltd

Indore

Shri Samir Shah

Director

Ciron Drugs & Pharmaceuticals Pvt Ltd Mumbai

Shri Devang Shah

Director

Aadivighnesh Chem Pvt Ltd

Mumbai

Shri Dipak Desai

Director

Aurochem Laboratories (India) Pvt. Ltd. Mumbai

Dr. Raja Sekhar Vundru, IAS

Joint Secretary

Department of Pharmaceuticals

Ministry of Chemicals & Fertilizers

Government of India

Sri B.K. Singh

Director

Department of Pharmaceuticals

Ministry of Chemicals & Fertilizers

Government of India

Sri Rajeev Kher, IAS

Addl. Secretary

Department of Commerce

Ministry of Commerce & Industry

Government of India

Alternative Member

Smt. Mridul Jain

Jt. Secretary

Department of Commerce

Ministry of Commerce & Industry

Government of India


Elected Members

Shri Omar H Shaikh

Director

Glow Pharma Pvt Ltd

Mumbai

Shri D.B.Mody

Director

J B Chemicals & Pharmaceuticals Ltd

Mumbai

Shri Rajeev Nannapaneni

Chairman & Managing Director

Natco Pharma Ltd

Hyderabad

Dr. Ranjit Puranik

Managing Director

Shree Dhootapapeshwar Ltd

Mumbai

Shri V V Krishna Reddy

Executive Director

Sri Krishna Pharmaceuticals Ltd Hyderabad

Shri Pranav Jayesh Choksi

Director

Gufic Biosciences Ltd

Mumbai

Shri Bhavin Mehta

Director

Kilitch Drugs (India) Ltd

Mumbai

Shri Nipun Jain

Director

Pharmchem

Delhi

Dr. V.Satyanarayana

Managing Director

Sipra Labs Ltd

Hyderabad

Sri Venkat Jasti

Chairman & CEO

Suven Life Sciences Ltd

Hyderabad


Co-Opted Members

Shri BR Sikri

ABS Merchantiles Pvt Ltd

Gurgaon

Shri Madan Mohan Reddy

Aurobindo Pharma Ltd

Hyderabad

Dr. A R Venkatesh

Global Pharma Health Care Pvt Ltd

Chennai

Shri Sanjay Srivastav

Maharishi Ayurveda Products Pvt. Ltd.

New Delhi

Dr. Patel Janmejay Hiru Bhhai

Nej Biotech

Nadiad

Shri Sanjiw Kumar Singh

Protech Biosystems Pvt Ltd

Gurgaon

Shri Ajay Pitre

Sushrut Surgicals Pvt Ltd

Shri Mukesh Sinha

Win-Medicare Ltd

New Delhi

Shri Dinesh Dua

Akorn India Pvt. Ltd.

Haryana

Shri SV Veerramani

Fourrts (India) Laboratories Pvt Ltd

Chennai

Shri George Patani

Inga Laboratories

Mumbai

Shri Tushar Korday

Medibios Laboratories Pvt Ltd

Mumbai

Shri Rajesh Jain

Panacea Biotec Ltd

New Delhi

Shri VV Krishna Reddy

Sri Krishna Pharmaceuticals Limited

Hyderabad

Shri Jayanth Tagore

Synthokem Labs Pvt Ltd.

Hyderabad


EXPORT PROMOTIONAL ACTIVITIES UNDERTAKEN DURING THE YEAR 2012-13

a) Southeast Asia Pharma & Healthcare show:

Council organized India Pavilion at Southeast Asia Pharma & Healthcare Show held during 17-

19th April 2012 at Kuala Lumpur, Malaysia. 22 companies participated in the event. It was 2nd

time Council participated in the event.

b) Visit to Ukraine and Azerbaijan

At the instance of Department of Commerce, Director General took part in the Indian

delegation to Ukraine and Azerbaijan, under the leadership of Shri Ravi Kapoor, Joint Secretary,

Department of Commerce during 11-18th April 2012. During the visit to Ukraine, it was

understood that that pharmaceuticals’ exports to Ukraine have almost come to a stagnant

position due to various reasons. The Ukrainian authorities have notified that they would

register medicines exported from countries which are members of PICS only. In case of

medicines which are to be imported from other countries, like India (who is not a member of

PICS), product registrations would be granted based on actual inspection by Ukrainian

authorities and full analytical testing of imported medicines, consignment-wise. In view of the

above, the exports of pharmaceuticals to India have been adversely affected and several

representatives of Indian pharma companies working in Kyiv (Ukraine) have requested

Pharmexcil to take immediate measures for improving the situation. Council took up the issue

and arranged for signing of MOU between Ukraine FDA and DCGI.

c) IPhEB, St. Petersburg:

Council participated in the 2nd edition of exhibition-cum-Conference for the first time by

taking about 180 sq.meters of space. Fourteen member companies participated in the event.

Meeting with local importers were organized with the help of organizers and Indian Mission.

d) Africa Health:

Council participated in Africa Health held at Johannesburg, South Africa during 9-11th May

2012 for the first time by organizing India Pavilion in 180 sq.meters of space. Though the

participants in our pavilion got reasonable business enquiries, the event being only the 2nd

edition, the visitors flow was not up to the expectations of participants.

H.E. Sri Virendra Gupta, High Commissioner of India in South Africa along with Sri Nandan

Singh Bhaisora, Acting Consul General in Johannesburg visited India Pavilion and interacted

with participants in our pavilion. He briefly explained about pharmaceutical market in South

Africa. Undue delays in issue of visas by South African embassy in India were brought to his notice

and he assured that he would take up this issue with external affairs ministry of South Africa.

International Events:


e) CPhI SEA

As part of Brand India Pharma project, Council participated in CPhI Southeast Asia held during

10-12th May 2012 at Jakarta, Indonesia. 35 member companies participated in the India

pavilion. Initially there was lots of resistance from local industry and government for extending

support to our Brand India Pharma Campaign. Even the Embassy was finding it difficult to get

support. However, after talking to senior members of local associations, an extremely strong

body in Indonesia, things have improved and highly successful Press Conference and Business

Seminar could be organized. Chairman and Vice-Chairman of GP FARMASI (National

Association) themselves participated actively in the business seminar. With the continued

efforts of Embassy, senior officials from Indonesian FDA also participated and made good

presentation. His Excellency Ambassador delivered his introductory speech and attracted

appreciation of all participants with his offer for collaborative investment in Indonesia. The

Department of Pharmaceutical services, Govt. of Indonesia has also sent an officer indicating

its interest to discuss with Pharmexcil / Government of India for attracting investment in their

API sector .

f) CPhI China 2012

Council participated and organized India Pavilion at CPhI China held during 26-28th June 2012.

Ten member companies participated in the pavilion. It was 3rd time Council participated in the

event.

g) Expo-BSM in Arogya, Sri Lanka – 17-19th August 2012

For the first time, Council organized Expo-cum-BSM in Sri Lanka during 17-19th August 2012.

At the advice of Indian Embassy in Sri Lanka, this BSM was organized along with ‘Arogya’ which

was organized by Government of Sri Lanka. 22 companies participated in the Expo. With help

of Indian embassy, Chamber of Commerce of Sri Lanka and local professional event managers,

Council made elaborate arrangements to invite local pharma buyers to the Expo. Over 200

pharma buyers visited and had business discussions with the exhibitors.

A few weeks before the above event, Hon’ble Minister for Commerce & Industry , Govt. of India

visited Sri Lanka, who assured the Sri Lankan Government all help from India in setting up

Industrial Parks in Sri Lanka. Subsequently, a Task Force was formed, where Executive Director

is one of the members. At the instance of Indian High Commission in Sri Lanka and officials of

department of Commerce, a delegation headed by Director General, comprising of

representative of five companies and Ramky Pharmacity, Executive Director of Pharmexcil,

visited Sri Lanka and held meetings with Ministry of Industries/Health to explore the

possibilities of setting up Pharma Industrial Parks in Sri Lanka. The visit of Indian delegation

was well publicized in the local papers. Government of Sri Lanka is very keen to set up Industrial

Parks in association with Govt. of India. Subsequently, Ramky Pharmacity had submitted a

proposal to Sri Lankan Government.


h) Delegation to LAC countries 1-15th Sep 2012

A trade delegation to Mexico, Guatemala, Panama and Costa Rica was organized during 1-15th

September 2012. Twenty one members participated in the delegation. One-to-One meetings

and Meetings with FDA officials were organized in all the places with the help of respective

Indian embassies.

i) Annual Meet – 26-28th Sep 2012

Council celebrated its 8th Annual Meet during 26-28th Sep 2012 coinciding its Annual General

Meeting at Hyderabad. Following activities had been organized during the Meet:

India – Asia Pacific Pharma Business Meet: 82 delegates from 68 pharma companies from 14

Asia Pacific countries attended the Business Meet and over 270 Indian delegates participated

and had fruitful business discussions.

Pharma CEOs Conclave: For the 3rd time, Council organized Pharma CEOs Conclave on 27th

Sept 2012. CEOs of Ranbaxy, Shasun, Laurus Labs, Vimta Labs, Natco Pharma have

participated in the Panel Discussion and Mr. Venkat Jasti moderated the discussions. Members

of Panel as well as participants actively participated in the discussions and expressed their

views / concerns on Indian Pharma’s target of achieving 25bn exports by March 2014. Sri J S

Deepak, Joint Secretary, who was the Chief Guest of the Conclave, positively received the

opinion of the participants and assured all possible assistance from Government of India.

Export & Patent Awards: Council conferred Export & Patent Awards to over 60 deserving

member companies. Sri Rajasekhara Vundru, Joint Secretary, Department of Pharmaceuticals,

Sri R P Thakore, Director General, AP Drug Control Administration had distributed the Awards.

j) CPhI Worldwide 2012

Brand India Pharma campaign, launched in CPhI Japan in March 2012, was continued in CPhI

Worldwide 2012. India was declared as focus country by the organizers of CPhI. Council

organized Business Seminars, Press meetings, participation in Innovation Awards, One-to-One

Meetings, Cultural programmes etc., with the help of Indian embassy in Spain and IBEF.

Secretary, Additional Secretary and Join Secretary of Department of Commerce participated.

The theme pavilion and India pavilion were well appreciated by the members and media.

Council advised all the member industries to extensively use the Rx logo so that the effect of

Brand India Pharma lasts long

k) Supplyside West:

Council participated in Supply Side West for the 3rd time by organizing India pavilion. There

were 10 companies participated through our pavilion. In view of better location this time, the

participants got good response and appreciated the efforts of Council.


l) Medica 2012:

Council participated in Medica 2012 held during 14-17th November 2012. This is 2nd time

council participated in the event. There were 10 companies participated in India Pavilion.

During Council’s participation in the previous year, there were some problems as part of the

area allocated was facing to the wall. This time, with lot of persuasion, the organizers divided

big block into the two parts so that there was more visibility to the participants.

m) CPhI India:

Council organized India-Pharmexcil Pavilion in CPhI India held during 21-23rd November 2012.

This was the 7th time Council participated in the event. As in the previous years, members

received good response during the show. Brand India Pharma designs were continued in this

event also.

n) Apteka

Council participated in Apteka held during 3-6th December 2012 at Moscow. Twenty one

companies took part in the India Pavilion. A BSM was organized in the same venue with the

help of our Mission in Moscow. His Excellency Ambassador of India in Russia attended event

and interacted with the participants.

o) Trade delegation to CIS countries

A Trade delegation to CIS countries (Russia, Moldova, Belarus and Turkmenistan) was organized

during 2-15th December 2012. Twenty four companies participated in the delegation. One-to-

one meetings with the local buyers and meetings with FDA officials were organized with the

help of embassies in all the four countries.

p) International Buyer-Seller Meet at IPC

Council organized International Buyer-Seller Meet coinciding 64th IPC held at Chennai during

7-9th Chennai. 36 prominent buyers from 22 countries were invited for the Meet and over 100

Indian delegates took part in the Meet

q) International Buyer-Seller Meet at World Ayurveda

Council organized International Buyer-Seller Meet coinciding 5th World Ayurveda Congress

held at Bhopal during 9-11th December 2012. Twenty five buyers from various countries and

over 110 Indian delegates participated in the Meet.

r) Trade delegation to Iran

At the instance of Department of Commerce, Council organized a trade delegation to Iran

during 17-19th December 2012. Twenty six companies participated in the delegation. Indian

Embassy in Iran and local Chamber of Commerce had extended its full co-operation in

organizing Business Meetings and meetings with Drug Regulatory authorities. As per


feedback, all participants got good response in the Business Meetings. Subsequent to the

delegation, Embassy sent a list of medicines in shortage, which do not require registration /

plant inspection. The list of was circulated to the members immediately.

s) Delegation to ASEAN countries

Council organized a trade delegation to Vietnam, Taiwan, Philippines and Singapore during 13-

26th January 2013. Mrs. Mridul Jain, Joint Secretary, Department of Commerce joined the

delegation for two countries i.e. Philippines and Singapore. Apart from organizing BSM in all

the places, a press conference was organized in Philippines and Biotech related conference in

Singapore. All the meetings were well attended by the local pharma companies. Delegates

from about 26 Indian companies benefited from the meetings.

u) RBSM at Vibrant Gujarat

International Business Meet inviting buyers from African countries was organized coinciding

Vibrant Gujarat during 8-10th January 2013 at Ahmedabad. There were about 60 buyers from

African countries and over 260 Indian delegates. Participated in the one-to-one meetings.

t) Arab Health

Council organized India pavilion at Arab Health 2013 held during 28-31st January 2013. 32

companies participated in the pavilion. It was the 8th time council participated in the event.

More pharma companies are interested to participate in this event in view of increasing

enquiries for pharma products from the visitors from Africa and GCC countries. During the

exhibition, all the visitors were informed about IPHEX and also efforts were made to identify

the buyers who can be invited as sponsored buyers.

v) Bio Asia

Council organized Business Meet/Technical Conferences on the occasion of BioAsia held at

Hyderabad during 28-30th January 2013 by inviting 30 international delegates. It was a good

opportunity for the overseas delegates to understand the developments that were taking place

in biotech / biopharmaceuticals front in India

w) BSM / Expo at Algeria & Nigeria

Council organized a BSM at Algeria and Expo at Nigeria during 3-8th March 2013. There was

good response from the members to participate in the event. 56 companies comprising of 76

delegates participated in the event. There was good response from the local buyers also.

About 120 delegates in Algeria and over 780 in Nigeria attended. In Algeria, His Excellency

Indian Ambassador, senior officials from Indian Embassy, big local pharma company

representatives participated in the dinner meet. His Excellency explained briefly about

Algerian markets, drug regulatory systems etc. For the benefit of local pharma companies, His

Excellency explained in detail about Indian pharma industry and its strengths, in French


language. The pre-event efforts of Indian embassy and our event manager showed good

results as there were about 123 local pharma delegates who attended the meet and interacted

with the Indian pharma delegates. As per the feedback received from Indian companies, all the

participants got good business leads.

In Nigeria, a dinner meet was organized by Pharmexcil at the Indian High Commissioner’s

office. His Excellency High Commissioner of India Sri Mahesh Sachdeva explained about

Nigerian markets, drug regulatory systems, strengths and weaknesses of Nigeria which have to

be considered while doing business with Nigeria. Sri Rajeev Kher , Additional Secretary also

addressed the gathering. Expo was inaugurated by His Excellency Sri Mahesh Sachdeva. Sri

Rajeev Kher, Additional Secretary, Department of Commerce, Govt. of India and Dr. Paul Ohrii,

Director General of NAFDAC, Nigeria were the other dignitaries on the dais. His excellency

said that Council’s efforts in operating a warehouse in Nigeria would help the Indian exporters

to stock and distribute their products. Press and media present in the inaugural meeting had

interaction with His Excellency High Commissioner and Additional Secretary, Director General,

NAFDAC, and Director General Pharmexcil.

Additional Secretary, Director General and Executive Director visited place where it is proposed

to open a warehousing facility by Pharmexcil for the benefit of exporters to Nigeria.


National Events:

a) Sri Lanka delegation to Hyderabad

There was a communication from High Commission of Sri Lanka in India stating that a high level

delegation lead by Hon’ble Dy. Minister for Industries, Government of Sri Lanka was visiting

India during 19-21st April 2012. The main purpose of their visit was to understand the

functioning of pharma clusters in India. The High Commissioners office requested Pharmexcil

to make arrangements for their visit to some clusters. Though it was not under purview of

Council, arrangements were made to visit to Genome Valley in Hyderabad and Pharma City in

Vizag. The delegation was well received by the organizers of Genome valley and Pharma City. A

mail was received from the Srilankan High Commissioners’ office appreciating the assistance

rendered by Pharmexcil.

b) Interactive meeting with DCGI:

On the occasion of Dr. G N Singh, DCGI visit to Mumbai, an interactive meeting was organized

on 26.4.2012, where about 20 members along with some of the Committee members attend

and discussed about various issues. Subsequently, a circular was issued to all members to

inform their issues so that all the issues would be compiled and submitted to DCGI for

consideration.

c) USFDA workshops

In association with DIA & US FDA, Pharmexcil organized workshops on Generic Drug

Applications with US FDA at Mumbai, Hyderabad, Goa and Chandigarh on 30th April, 2nd, 4th,

7th May 2012 respectively. Two senior officials from US FDA participated in the workshops.

With the financial support from Department of Pharmaceuticals, Council offered a concession

of Rs.2000/- per participant, subject to a maximum of 40 participants at each place. Since it

was an important and useful subject for the members, Council put efforts in communicating to

the members about the workshops. There was good response for the workshops at all the

places. Over 200 professionals participated.

d) Interactive meeting with Controller General Patents:

On the occasion of Sri Chaitnya Prasad taking over as new Controller General of Patents,

Pharmexcil organized an interactive dinner meeting on 2nd May 2012 at Mumbai. Joint

Secretary of Department of Pharmaceuticals also participated in the meeting.

e) Visit of Hon’ble Minister to Brazil 14-17th June 2012

At the instance of Department of Commerce, Council joined the delegation led by Hon’ble

Minister for Commerce & Industry to Brazil during 14-17th June 2012. Representatives of

Fifteen of our member companies joined the delegation. Executive Director participated on

behalf of Council


f) Meeting with DCGI at Hyderabad

During the visit of Sri G N Singh, DCGI to Hyderabad on 196.2012, an interactive meeting with

Pharma related associations was organized by the office of DDC(I). Sri Venkat Jasti, Dr. V

Satyanaryana, Director General and Regional Director attended on behalf of Council. A circular

was sent to members informing about the meeting and collected inputs. A presentation

compiling the issues raised by members was presented by Director General in the meeting.

g) Interactive meeting with Ambassador designate to Tanzania

Sri Debanth Shah, Ambassador Designate to Tanzania was in India during the last week of June

2012, who was keen to meet the pharma exporters to Tanzania and find out issues, if any.

Accordingly, an interactive meeting was organized on 22nd June 2012, which was well attended

by our members.

h) IPR & Regulatory meeting

With fund support from Department of Pharmaceuticals, a seminar on IPR and Regulatory

matters was organized on 22nd June at Mumbai. Dr. Gopakumar Niar, Mrs. Rubeena Ansari,

Mrs. Andreya Fernades, Dr. S Padmaja, Dr. Mlind Joshi made presentations on IPR and

Regulatory subjects.

i) Interactive meeting with DG, AP Drug control administration

With a view to help the exporters of AP State to interact with the Director General and other

senior officials of AP Drug Control Administration, council organized a meeting on 5th July 2012

at Hyderabad. About 60 members participated and interacted with the officials.

j) Consultative committee meeting

Department of Commerce held First Pharma Consultative Meeting under the chairmanship of

Hon’ble Minister for Commerce, Industry and Textile on 3rd July 2012. Sri Lanka Srinivas made

a presentation as member of the group. Council provided the assistance as required by DoC.

k) Seminar on Regulatory / IPR at Chennai

With the financial assistance from Department of Pharmaceuticals, Council had organized a

Seminar at Chennai on 24th August 2012 on Regulatory & IPR. Advisor – Patent Facilitation

Center had assisted the council in organizing the event successfully. About 50 members

participated.

l) Seminar on Recent changes on Service Tax

Hyderabad Chapter of Rotary club organized a seminar on recent changes on Service Tax on 22-

08-2012. Council co-organized the event by extending a nominal financial assistance to the

organization. Good number of our members also participated and got clarifications on Service tax


m) Interactive Meeting with European Commission

On the occasion of Mr. Stefan Fuehring, Policy Officer, looking after quality, safety and efficacy of medicinal products in the Directorate General of Health and Consumers, European Commission visit to Hyderabad, Council organized an interactive meeting on 13.9.2012 at Hyderabad. He made a presentation on Quality of Medicines and Technology Solutions on Falsified Medicines and EU Directive on New rules on importing APIs into the European Union. About 60 members participated and interacted with him.

n) Interactive meeting with senior officials of AYUSH department

Joint Secretary and other senior officials of Department of Ayush Department, New Delhi had visited Hyderabad on 15th Sept 2012 on the occasion of Bio-diversity programme. Taking advantage of their presence in Hyderabad, Council organized interactive meeting with them for the benefit of members in AYUSH sector. CEO of AP Medicinal Plant Board, CEO of National Medicinal Plant Board, Director of CIMAP, Commissioner of Ayush also participated and interacted with the members. About 35 members participated in the meeting event with short notice.

o) Interactive Meeting with Chairman of Exim Bank

Council organized an interactive meeting with the Chairman of Exim Bank on 30th November 2012 at Hyderabad. About 30 members attended the meeting and interacted with the Chairman and other senior officials of Exim Bank. Presentation made in the interactive meeting was made available in the website.

p) UKTI-FDCA Meetings:

Council associated with UK Trade & Investment in organizing interactive meetings at Mumbai, Hyderabad and Ahemdabad. In order to take advantage of senior officers visiting from MHRA, Council organized meetings with DCGI also at Delhi.

q) Market Quick start programme

For the benefit of members in Herbal/Nutraceuticals sector, Council, in association with Engredea, USA organized a ‘Market Quick Start programme’ on 3rd December 2012 at Hyderabad. About 25 companies participated in the meeting.

r) Interactive meetings with GS1 at Ahemdabad and Mumbai

At the instance of DGFT, GS1 organized workshop/webinars at Mumbai and Ahmedabad on

17th and 19th December 2012 to enlighten the exporters about bar coding on secondary

packing. During the interactive meetings, there were some issues as regards to mono cartons.

As per earlier GS1 guidelines, mono cartons were considered as Primary packing, which was

later on changed to Secondary packing. It was understood that GS1 stated that the change was

made at the instance of Council, whereas there was no such communication from Council side

to this effect. Secretariat immediately took up the issue with GS1. Subsequently, GS1 made

the necessary changes in the guidelines making mono cartons as Primary packing.


s) Interactive meeting with Unani exporters:

At the request of Medicinal Plant Board, AP, Council organized an interactive meeting with the

exporters of Unani medicines on 22nd December 2012 at Hyderabad. About 20 exporters

participated and interacted with the officials of Medicinal plant board.

t) Interactive meeting on EU directive & IPHEX at Mumbai

Keeping in view importance of the issue of EU directive, Council organized an interactive

meeting on this subject on 4th February 2013 at Mumbai. This meeting was well attended by

members, who appreciated the efforts of Council. During this meeting members were also

informed by Council’s flagship event ‘IPHEX’ and invited their participation.

u) Meeting with Serbian visitors

Council received a communication from Embassy of Serbia that some pharma companies was

visiting India looking for herbal/dietary products. Council circulated the information to the

members asking them to fix up meetings with the delegates directly. As many members could

not get opportunity to meet them, Council organized a dinner meet also on 21st February 2013

with the Serbian pharma companies and many members participated and interacted with the

delegation.

v) Interactive meeting on Foreign Trade policy

At the advice of Jt. DGFT, Hyderabad, an interactive meeting with the exporters was organized

on 14th February 2013 at Hyderabad. Council compiled all the points/issues received from the

members and submitted to the senior officials attended the Interactive meeting from Ministry

of Commerce/DGFT.

w) Meeting with Ambassador in India on IPHEX

A meeting with Ambassadors of various countries in India was organized in New Delhi to inform

about launching of IPHEX. Road Shows also organized in Mumbai and Ahmedabad.


Other Important activities under taken / Representations made:

a) New EU Directive for export of APIs:

European Union had announced a new Directive for export of APIs which comes into effect from 1.7.2013. As per the new directive, either India is to be listed as one of the countries conforming to EU GMP or every API exporters to EU are required to submit a Written Confirmation issued by a Competent Authority stating that the unit conforms to WHO GMP standards. Immediately after announcing this Directive, Pharmexcil, after consultation with the industry, represented to Department of Commerce / DCGI explaining the implication of the Directive. Based on the feedback from industry during many interactive meetings organized by Pharmexcil, Government announced DCGI as Competent Authority for issuing Written Confirmations. After the announcement of Competent Authority, Council interacted with office of DCGI & industry in finalizing the guidelines for issuing Written Confirmations.

b) Bar coding:

With the vacation of stay order on implementation of bar coding by Hon’ble High Court of Madras, notification issued by DGFT on bar coding on secondary & primary packing with effect 1.7.2013 had become compulsory. As industry was not ready for implementing bar coding on primary packing, Council made several representations for exemption of bar coding on primary packing. Considering the requests from industry, Department of Commerce extended the time for implementing bar coding on primary packing till 1.7.2014. Thus bar coding on secondary packing came into effect from 1.7.2013. Pharmexcil continuously helping the industry in sorting out various issues, like requirement of bar coding for the batches produced 1.7.2013, requirement of bar coding for APIs, definition of mono cartons etc. with the help of Department of Commerce / DCGI

c) Service Tax on Commission paid to agents:

Council sent a representation to DGFT requesting for increasing the limit of exemption of FOB value from 1% to 1.2% subsequent to increase of rate of Service Tax from 10% to 12%

d) Excess interest by Customs:

Council represented to DGFT bringing to its notice that Customs is charging interest on unitized imports under Advance Licenses @ 18% as per their notifications against 15% allowed as per DGFT notification and requested to consider to charge at 15% in view of problems faced by exporters.

e) Issue of Licenses for APIs not covered under DCGI List

A representation was made to DCGI bringing the problems faced by the exporters in case of exporting old APIs not covered in the list of DCGI, though such products have been exported over the past 15 years. It was suggested to delegate the powers to Zonal offices for issuing such licenses or process the applications by DCGI Delhi on fast track basis within a time frame of 7 days.


f)Issues of Nutritional Products:

There were many complaints from members dealing with nutritional products that they were facing lot of problems subsequent to the commencement of operations by FSSAI. Council brought their issues to the notice of DoC. Department had taken up the issues actively and met the officials of FSSAI and DGFT officials to sort out the same

g) Issue of Licenses without brand names

Another major issue handled by Council was the decision taken by DCGI to issue Licenses without brand names. The notification caused lot of confusion among the exporters as the exports were expected to hampered severely. Council immediately sent out a circular seeking the views of members. Based on the feedback from the members , Council sent a representation to DCGI requesting to consider issuing Licenses with brand names for export purpose. Council’s representation was considered favourably and Department of Health sent a communication on 9.11.2012, clarifying that the earlier notification is not applicable for issue of CoPPs, GMP certificates, Free Sale Certificates etc.

h) Representation to AP Drug Administration on CoPPs:

Some of the members informed that AP Drug Administration was issuing the CoPPs for each product and per country basis at a cost of Rs.500 for each certificate. Director General along with representatives of BDMA met the DG, AP Drug Control Administration and gave a representation requesting them to issue CoPPs for each product manufactured by the companies without mentioning country name.

I) Compilation of important information:

With the help of ex-CDSCO official, list of WHO GMP certified units in India was compiled and CD was prepared. Along with this information, the CD contains information about DMFs/ANDAs filed by Indian companies with USFDA, CoS issued by EDQM etc. Council had sent these CDs to various embassies, given to visitors at various exhibitions, free cost.

j) World Pharma Trade Center:

With lot of persuasion by Pharmexcil, AP Government agreed to allot 3/5 acres of land at Hi-tech city, Hyderabad, for establishing World Pharma Trade Center. Council would further pursue with the concerned departments for allotment of land soon.

k) List of MoUs Signed by PHARMEXCIL

a) Chinese Association for Pharmaceuticals Agents Taiwan

b) India Colombia Chamber of Commerce & Industry Bogota

c) Ghana National Chamber of Commerce & Industry Accra

d) Empower School of Health New Delhi


e) Association of Generic Medicines of Nepal Kathmandu

f) Pharmaceutical Society of Nigeria & Association of Lagos Industrial Pharmacist Nigeria

g) China Chamber of Commerce for Import and Export Beijing of Medicines and Health Products

The main objective of above MoUs is exchange of information and co-operation in export related subjects.

Workshop on Regulatory Compliances in Japan, New Delhi - 26th July 2012

Interactive Meeting with DG, Drugs Control Administration, AP, Hyderabad - 05th July 2012


Workshop on Regulatory Compliances in Japan for Pharmaceuticals, Mumbai - 27th July 2012

Workshop on Regulatory Compliances in Japan for Pharmaceuticals, Mumbai - 27th July 2012

India Pavilion at AROGYA Colombo, Sri Lanka 17-19th August 2012

Open House Meet with Secretary, Department of Commerce & Director General of Foreign Trade, Hyderabad - 21st July 2012

Open House Meet with Secretary, Department of Commerce & Director General of Foreign Trade, Hyderabad - 21st July 2012

Interactive Meeting with European Commission, Hyderabad - 13th September 2012


Seminar on Building Partnerships with Indian Pharmaceutical Industry & the Launch of iPHEX 2013, New Delhi - 24 Sep 2012

Seminar on Building Partnerships with Indian Pharmaceutical Industry & the Launch of iPHEX 2013, New Delhi - 24 Sep 2012

Seminar on Recent Changes in Service Tax, Hyderabad - 25th August 2012


INDIA - ASIA-PACIFIC Pharma Business Meet, Hyderabad - 26-28th Sep 2012




Pharma CEOs Conclave, Hyderabad - 27th Sep 2012 Pharma CEOs Conclave, Hyderabad - 27th Sep 2012

Export & Patent Awards 2011-12, Hyderabad - 28th September 2012


Interactive Meeting with Senior officials, Dept. of AYUSH & National Medicinal Plant Board, Hyderabad - 15th October 2012

Pharmexcil's International Business Meet (RBSM) 64IPC, Chennai - 7-9th Dec 2012

Pharmexcil's International Pharma Business Meet - Vibrant Gujarat, Ahmedabad - 9-11th Jan 2013


Pharmexcil's International Business Meet (BSM) 10th BioAsia, Hyderabad - 28-30th Jan 2013






AUDITORS REPORT TO THE MEMBERS OFPHARMACEUTICALS EXPORT PROMOTION COUNCIL OF INDIA, HYDERABAD.

1. We have audited the attached Balance Sheet of M/s Pharmaceuticals Export Promotion

Council of India as at March 31, 2013 and the Income and Expenditure under the reference

to this report. These Financial Statements are the responsibility of the Company’s

management. Our responsibility is to express an opinion on these financial statements

based on our audit.

2. We have conducted our audit in accordance with generally accepted auditing standards in

India. These standards require that we plan and perform the audit to obtain the reasonable

assurance whether the financial statements are free of material misstatements. An audit

includes, examining on a test basis, evidence supporting the amounts and disclosures in the

financial statements. An audit also includes assessing the accounting principles used and

significant estimates made by management, as well as evaluating the overall financial

statements. We believe that our audit provides a reasonable basis for our opinion.

3. The provisions of companies (Auditors Report) Order, 2003, issued by the central

Government of India in terms of Section 227 (4A) of The Companies Act, 1956, are not

applicable to the Company, as M/s Pharmaceuticals Export Promotion Council of India is

registered as a company Licensed to operate Under Section 25 of the Companies Act, 1956.

4. Further, We report that-

a) We have obtained all the information and explanations, which to the best of our knowledge

and belief were necessary for the purposed of our audit.

b) In our opinion, proper books of account as required by law have been kept by the company,

so far as appears from our examination of those books.

c) The Balance Sheet and Income and Expenditure Account dealt with by this report are in

agreement with the books of account.

d) On the basis of written representations received from the directors as on 31st March, 2012

and taken on record by the Board of Directors, we report that none of the directors is

disqualified as on 31s March, 2012 from being appointed as a director in terms of clause (g)

of sub-section (1) of section 274 of the companies Act, 1956.


e) The Company has neither paid not provided for cess payable u/s 441A of the Companies

Act, 1956 since the aforesaid section is not yet been made effective by the Central

Government.

f) In our opinion, and to the best of our information and according to the explanations given to

us, the said accounts together with the notes thereon/ attached thereto give in the

prescribed manner the information required by the Act, and also give a true and fair view in

conformity, with the accounting principles generally accepted in India.

I. In the case of the Balance Sheet, of the state of affairs of the Company as at March 31,

2013.

ii. In the case of Income and Expenditure Account, of the EXCESS of Income and

Expenditure for the year on that date.

For Sarath & AssociatesFirm Regd. No. 005120sChartered Accountants

CA. S. SRINIVASPARTNER – M. NO. 202471

PLACE : Mumbai (Camp) DATE : 05 - 09 - 2013


PHARMACEUTICALS EXPORT PROMOTION COUNCIL OF INDIA(LIMITED BY GUARANTEE)

BALANCE SHEET AS AT 31st March, 2013

CORPUS FUND & LIABILITIES SCH. As at 31.03.2013 As at 31.03.2012

Corpus Fund 30,000,000 30,000,000

Reserves & Surplus 1 5,802,820 5,111,090

Capital Grants 2 519,056 1,020,951

Advances from Govt.of India 3 6,845,979 37,485,358

Current Liabilities & Provisions 4 62,463,028 31,893,238

Excess of Income over Expenditure 4 (A) 46,404,255 33,299,184

152,035,138 138,809,821

ASSETS SCH. As at 31.03.2013 As at 31.03.2012

Fixed Assets 5 3,116,038 2,904,775

Investments 6 48,983,244 41,782,481

Current Assets, Loans & Advances 7 99,935,856 94,122,565

152,035,138 138,809,821

Vide our Report of Even Date

For SARAT & ASSOCIATES FRN: 005120S Chartered Accountants Sd\-


For Pharmaceuticals Export Promotion Council of India

Director General ChairmanExecutive Director



INCOME & EXPENDITURE ACCOUNT FOR THE YEAR ENDED 31ST MARCH, 2013

INCOME SCH. As at 31.03.2013 As at 31.03.2012

Membership Fees 8 23,877,782 25,070,419

Contributions from Members 9 108,340,375 51,513,451

Income from Investments 10 6,416,680 6,534,471

Other Income 11 453,969 1,986,422

139,088,806 85,104,763

EXPENDITURE SCH. As at 31.03.2013 As at 31.03.2012

Expenses on Coded Activities 12 95,993,341 48,742,442

Establishment Expenses 13 16,136,785 13,536,497

Other Administrative Expenses 14 13,519,013 15,037,240

Depreciation on Assets 5 334,596 277,310

125,983,735 77,593,489

Surplus for the year carried to Schedule 1 A 13,105,071 7,511,274

Vide our Report of Even Date

For SARAT & ASSOCIATES FRN: 005120S Chartered Accountants Sd\-


For Pharmaceuticals Export Promotion Council of India

Director General ChairmanExecutive Director


PARTICULARS As at As at 31.03.2013 31.03.2012

SCHEDULE - 1

RESERVES & SURPLUS

ENTRANCE FEE

As per last Balance Sheet 5,111,090 4,459,955

Add: Entrance Fee collected during the year 691,730 5,802,820 651,135 5,111,090

5,802,820 5,111,090

SCHEDULE - 2

CAPITAL GRANTS

As per last Balance Sheet 1,020,951 1,436,917

Add: Received during the year 0 0

1,020,951 1,436,917

Less: Adjustments during the year 501,895 519,056 415,966 1,020,951

(60% of depn on assets for which Grant recd. from Govt)

519,056 1,020,951

PHARMACEUTICALS EXPORT PROMOTION COUNCIL OF INDIASCHEDULES TO THE ANNUAL ACCOUNTS FOR THE YEAR ENDED 31st March, 2013


SCHEDULE - 3 As at As at 31.03.2013 31.03.2012

(A) ADVANCE FROM GOVT.OF INDIA(I) Advances under MDA Scheme Refundable

to the extent remaining unutilisedAs per last Balance Sheet 1,027,955 2,430,381Add: Received during the year 27,182,000 28,209,955 16,000,000 18,430,381

Less: UTILISED BY THE COUNCIL (i) For Specific Code Activities 27,182,000 14,972,045 (ii) Amount returned to Ministry 1,027,955 28,209,955 0 2,430,381 17,402,426 1,027,955

(II) Advances under Exporters MDA Claims (Refundable to the extent remaining unutilised)As per Last Balance Sheet 13,151,437 3,654,631Add: Received during the year 13,500,000 26,651,437 21,010,000 24,664,631

Less: Amount returned to Ministry 9,750,573 0 Less: MDA disbursed during the year 14,018,538 23,769,111 2,882,326 11,513,194 11,513,194 13,151,437

(III) Advances under MAI Scheme (Refundable to the extent remaining unutilised)As per Last Balance Sheet 15,077,252 2,710,000Add: Received during the year - Reimbursement of Product Regn. charges 27,077,445 53,230,353 - Grants received for activities under MAI 32,920,000 27,824,000 - Grants receivable for activities under MAI 39,079,695 99,077,140 14,833,796 95,888,149

114,154,392 98,598,149

Less: Disbursed during the year - Product Registration Charges 35,191,044 42,863,101 - Utilised for CPHI-PARIS 0 1,000,000 - Utilised for Activities under MAI Scheme 74,999,695 110,190,739 3,963,653 39,657,796 83,520,897 15,077,252

(IV) Advances from Ministry of Chem & Fertilizers Refundable to the extent remaining unutilised

As per last Balance Sheet 928,714 1,417,614Add: Received during the year 0 928,714 0 1,417,614

Less: Returned to Ministry 0 0 Less: Utilised during the year 928,714 0 488,900 928,714

(B) GRANTS RECEIVED FOR IPR CELLAs per last Balance Sheet 7,300,000 0 Add: Received during the year 0 7,300,000 7,300,000 7,300,000Less: Utilised during the year 7,300,000 0 0 7,300,000

6,845,979 37,485,358

PHARMACEUTICALS EXPORT PROMOTION COUNCIL OF INDIASCHEDULES TO THE ANNUAL ACCOUNTS FOR THE YEAR ENDED 31ST MARCH, 2013



CURRENT LIABILITIES & PROVISIONS

Sundry Creditors for Expenses 20,079,902 9,929,065

Outstanding Expenses 19,765,076 15,240,345

TDS Payable 442,226 265,569

Advance Contributions from Members 22,040,556 6,204,686

Service Tax 135,268 0

Visa Fee to be returned to Members 0 62,463,028 253,573 31,893,238

62,463,028 31,893,238

SCHEDULE - 4(A)

EXCESS OF INCOME OVER EXPENDITURE

Opening Balance 33,299,184 25,787,910

Add: Surplus as per Income & Exp. Account 13,105,071 46,404,255 7,511,274 33,299,184

46,404,255 33,299,184



PH

AR

MA

CE

UT

ICA

LS

EX

PO

RT

PR

OM

OT

ION

CO

UN

CIL

SC

HE

DU

LE

S T

O T

HE

AN

NU

AL

AC

CO

UN

TS

FO

R T

HE

YE

AR

EN

DE

D 3

1st

Marc

h, 2013

(A

mo

un

t in

Rs.

) S

CH

EDU

LE -

5

FIX

ED A

SSET

S

G

RO

SS B

LOC

K

DEP

REC

IATI

ON

N

ET B

LOC

K

PA

RTI

CU

LAR

S A

s o

n

Ad

dit

ion

s A

s o

n

Up

to

Pro

vid

ed

U

pto

A

s o

n

As

on

0

1-0

4.2

01

2

du

rin

g 3

1.0

3.2

01

3

31

.03

.20

12

d

uri

ng

31

.03

.20

13

3

1.0

3.2

01

3

31

.03

.20

12

th

e Y

ear

th

e Y

ear

Lea

se h

old

lan

d

3

00

,00

0

14

1,7

00

4

41

,70

0

0

0

0

44

1,7

00

3

00

,00

0

Veh

icle

s

9

.50

%

1,0

65

,92

3

0 1

,06

5,9

23

2

09

,73

9

10

1,2

63

3

11

,00

2

75

4,9

21

8

56

,18

4

Co

mp

ute

rs

1

6.2

2%

3

,19

1,1

94

0

3,1

91

,19

4

2,5

65

,64

7

51

7,6

12

3

,08

3,2

59

1

07

,93

5

62

5,5

47

Off

ice

Equ

ipm

ents

4.7

5%

6

18

,80

4

90

6,0

54

1

,52

4,8

58

7

6,2

61

3

4,5

91

1

10

,85

2

1,4

14

,00

6

54

2,5

43

Inta

ngi

ble

Ass

ets

-

16

.22

%

28

7,1

11

0

28

7,1

11

2

76

,29

3

10

,81

8

28

7,1

11

0

1

0,8

18

So

ftw

are

Fu

rnit

ure

& F

ixtu

res

6

.33

%

18

0,3

62

0

18

0,3

62

7

1,6

55

1

1,4

17

8

3,0

72

9

7,2

90

1

08

,70

7

Co

mp

ute

rs -

IPR

CEL

L 1

6.2

2%

9

91

,31

2

0 9

91

,31

2

53

0,3

36

1

60

,79

1

69

1,1

27

3

00

,18

5

46

0,9

76

T

OTA

L 6

,63

4,7

06

1

,04

7,7

54

7

,68

2,4

60

3

,72

9,9

31

8

36

,49

1

4,5

66

,42

2

3,1

16

,03

8

2,9

04

,77

5

To

tal D

epre

ciat

ion

fo

r th

e ye

ar

83

6,4

91

Les

s: 6

0%

Dep

reci

atio

n c

har

ged

to

Cap

ital

Gra

nt

A/c

. 5

01

,89

5

Bal

ance

Dep

reci

atio

n f

or

the

year

tak

en t

o In

com

e &

Exp

A/c

3

34

,59

6




INVESTMENTS

Fixed Deposits with Corporation Bank,Hyderabad 30,000,000 30,000,000

TDR - Flexi with Corporation Bank, Hyderabad 0 2,450,000

Fixed Deposits with Corporation Bank,Hyderabad 18,983,244 48,983,244 9,332,481 41,782,481

48,983,244 41,782,481

SCHEDULE - 7

CURRENT ASSETS, LOANS & ADVANCES

CURRENT ASSETS

Cash in hand 83,938 249,703

Bank Balance 30,241,838 61,256,335

Foreign Currency 0 30,325,776 896,997 62,403,035

LOANS & ADVANCES

Rent Deposit 842,022 755,022

Other Deposits 34,915 2,915

Interest accrued on deposits 2,902,769 410,444

TDS Receivable 6,477,682 3,363,907

Advance for expenses - Delhi Office 308,301 8,301

Amount receivable from GOI for activities under MAI Scheme 39,079,695 18,342,649

Amount receivable from IPC for RBSM-Chennai 1,500,000 0

Advance to staff 128,519 141,880

Brand Promotion Funds Receivable from IBEF, Delhi 5,246,949 5,823,160

Advances paid for 2013-2014 Activities 12,745,756 2,871,252

Tour Advances to Staff 343,472 69,610,080 0 31,719,530

99,935,856 94,122,565

SCHEDULE - 8

MEMBERSHIP FEE

Membership Fee 23,877,782 25,070,419

23,877,782 25,070,419

SCHEDULE - 9

CONTRIBUTION FROM MEMBERS

Participation charges - Exhibitions/Trade Fairs 77,864,674 23,844,396

Participation charges - Delegations 2,597,149 3,582,610

Participation charges - Reverse Delegations 27,569,617 23,247,170

Advertisement charges 308,935 108,340,375 839,275 51,513,451

108,340,375 51,513,451

SCHEDULE - 10

INCOME FROM INVESTMENTS

Interest on Fixed Deposits

- on Corpus Fund of Rs.300 Lakhs 3,540,251 3,441,974

- on fixed deposits with scheduled banks 2,876,429 6,416,680 3,092,497 6,534,471

6,416,680 6,534,471




OTHER INCOME

Sale of Publications 103,600 340,300

Certification Charges 205,659 126,700

Other Income 144,710 453,969 1,519,422 1,986,422

453,969 1,986,422

SCHEDULE - 12

EXPENSES ON CODED ACTIVITIES

Activities under MDA Scheme

Exhibitions/Trade Fairs outside India 56,562,666 30,076,919

Delegations outside India 14,962,417 8,473,516

Export Promotion Seminars & Meetings 0 1,415,830

Reverse Delegations 26,485,828 16,447,778

Publicity & Canvassing - Abroad 714,127 98,725,038 1,549,684 57,963,727

Activities under MAI Scheme

Arab Health - 2013 7,092,751 8,596,483

RBSM held at WAC, Bhopal(2012-13) 3,288,349 3,887,892

Global RBSM in 64th IPC, Chennai 8,015,685 5,681,414

India - LAC Pharma Business Meet, Hyderabad 0 13,207,011

Arogya Srilanka(2012-13) 3,945,176 2,382,791

St.Petersburg (2012-13) 1,096,380 4,729,875

RBSM at Vibrant Gujarat 6,594,308 0

Bio Asia 2013 5,285,240 9,915,930

CPHI - World wide 2012 (2012-13) 62,208,141 97,526,030 0 48,401,396

Activities without MDA Assistance 1,923,968 410,320

(A) : Expenses on Coded Activities 198,175,036 106,775,443

Less: MDA Grants received from Govt.of India 27,182,000 14,972,045

MAI Grants received from Govt.of India 74,999,695 33,237,796

Grants Received from Govt.of A.P. for Bio-Asia 0 4,000,000

Funds from IBEF for Branding at Cphi-Japan 0 5,823,160

(B) : Total Grants received 102,181,695 58,033,001

(A) - (B) 95,993,341 48,742,442




ESTABLISHMENT EXPENSES

Salaries 13,843,207 11,186,995

Exgratia to Employees 709,092 602,523

Staff Mediclaim Policy 34,228 59,817

Medical Expenses 222,194 70,962

Staff Welfare Expenses 649,299 337,785

L.T.A 0 703,537

E.P.F Employer's Contribution 678,765 16,136,785 574,878 13,536,497

16,136,785 13,536,497

SCHEDULE - 14

OTHER ADMINISTRATIVE EXPENSES

Audit Fee (Statutory & Internal Audit) 168,540 112,360

Advertisement Expenses 24,000 52,500

Bank Charges 146,166 191,617

Books & Periodicals 34,540 43,553

Building Maintenance 134,416 122,056

COA Meeting Expenses 22,694 592,594

Consultancy Charges 1,186,800 1,856,575

Conveyance 1,722,392 1,584,862

Electricity Charges 1,074,127 786,709

H.R.Services 455,600 0

Internet/Website 472,519 510,603

Office Expenses 961,252 2,108,126

Postage & Courier 602,389 405,381

Printing & Stationery 423,229 549,595

Rent 2,834,220 2,852,514

Telephone 657,141 587,608

Travelling Expenses 1,540,095 1,602,915

Subscriptions 24,490 0

Exchange Rate Flucutuation 355,514 0

Vehicle Maintenance 168,160 163,003

Repairs & Maintenance 424,255 808,816

Insurance 86,474 13,519,013 105,853 15,037,240

13,519,013 15,037,240



SIGNIFICANT ACCOUNTING POLICIES & NOTES ON ACCOUNTS ANNEXED TO AND FORMING

PART OF FINANCIAL STATEMENTS FOR THE YEAR ENDED 31st MARCH, 2013

I. SIGNIFICANT ACCOUNTING POLICIES:

1.1 GENERAL

a) The Financial Statements are prepared on the basis of historical cost convention, in

accordance with applicable accounting standard and on the basis of going concern.

b) Entrance Fee receipts are credited to General Reserve.

1.2 FIXED ASSETS

Fixed Assets are stated at cost of acquisition, less accumulated depreciation.

1.3 DEPRECIATION

Depreciation on Fixed Assets is provided on straight Line Method at the rates and in the manner

prescribed in Schedule XIV of the Companies Act, 1956 in respect of assets acquired during the

year, depreciation has been provided on the pro-rata basis, duly applying the necessary rate.

1.4 INVESTMENTS

Investments are stated at cost. Interest on the same is being accounted for on accrual basis.

1.5 TRANSACTIONS IN FOREIGN CURRENCY

Transactions in foreign currency are recorded at the rate of exchange in force at the time of

occurrence of the transaction.

II. Notes on Accounts

2.1 M/s. Pharmaceuticals Export Promotion Council of India (hereinafter called “Pharmexcil”)

is promoted by Ministry of Commerce & Industry, Government of India and had been

registered as Company under section 25 of the Companies Act, 1956 and by virtue of the

provisions of Companies Act, the word “LIMITED” is not required to be suffixed in its’ name.

2.2 M/s. Pharmexcil has been set up by the Ministry of Commerce & Industry to act as Nodal

Agency for issue of Registration cum Membership Certificate the Pharmaceutical exports

throughout the country under the provisions of Foreign Trade Policy being announced by Govt.

of India from time to time.

2.3 As M/s. Pharmexcil is a Section 25 Company not for Profit, Income & Expenditure Account

has been prepared instead of Profit & Loss Account.


2.4 The expenses in respect of code activities are subject to sanction/confirmation of the

Government of India and Grant-in-aid received from the Ministry of Commerce is subject to

adjustments on account of Government Audit objections, if any, partial/non fulfillment of

conditions laid down for eligibility of such Grant-in-aid, clarification by M/s. Pharmexcil and the

final decision of the Ministry in respect of the same.

2.5 Of the total depreciation computed in accordance with Schedule XIV of the Companies Act,

60% is adjusted against the Capital Grant given by the Government of India for acquiring theses

assets and balance amount is charged to Income & Expenditure Account.

2.6 Unutilized MDA advance of the beginning of the year stood at Rs.10,27,955/- and during

the year under review, the amount of Advance received from Ministry of Commerce under this

head stood at Rs.2,71,82,000/-. As against this, the amount utilized during the year was

Rs.2,71,82,000 /- and amount returned back to Ministry was Rs.10,27,955/- and accordingly,

the closing balance is Nil.

2.7 Pursuant to the approval by the Ministry of Commerce for grant of Marketing Development

Assistance(MDA) to individual exports under certain eligible scheme, M/s. Pharmexcil has,

during the year, reimbursed the members Rs.1,40,18,538/-(Previous year 1,15,13,194/-).

2.8 During the year under review, an amount of Rs. 3,51,91,044/- was utilized for

reimbursement of Product Registration Charges received under MAI Scheme

2.10 There are no dues to small Scale/Ancillary Industrial Undertaking as at the Year end.

2.11 Membership Fee was accounted on receipt basis and accordingly, no provision has been

made for Membership dues for the year.

2.12 The Council is registered under Section 12AA of the Income Tax Act, 1961 and accordingly,

no income tax is payable on the surplus, subject to the fulfillment of the conditions laid down

for this registration. One of the conditions laid down in this regard is spending of the amounts

pertaining to accumulation of income within the specified period (5 years). Non-compliance of

this may result in tax on the portion of the accumulated income not utilized for the purpose. In

the case of Council, this amount remaining unutilized for the purpose within the period of 5

years amounted to Rs.60,00,000, which may come under the tax levy. The Council is taking

steps of filing an application before the Assessing Authority seeking additional time for fulfilling

this obligation.

Vide our Report of Even Date For Pharmaceuticals Export Promotion Council

For SARAT & ASSOCIATES

FRN: 005120SChartered Accountants

CA. S. SRINIVAS Executive Director Chairman

PARTNER – M. NO. 202471

Date: 05.09.2013


List of Circulars for the Year 2012-13

Sl No Date Subject

1 29-Mar-13 Revised - India Pavilion at CPhI Japan from 24-26th April 2013

1 4-Apr-12 India Pavilion Participate in Vita Foods(FPE) at Geneva, Switzerland 22-24 May 2012

2 7-Apr-12 Global Pharma Tenders - Weekly Alerts: March 6th, 2012

3 12-Apr-12 India Pavilion in CPhI India 21-23rd November 2012 Mumbai

4 13-Apr-12 US FDA Workshops on Generic Drug Applications 30th April, 2nd May, 4th May and 7th May 2012

5 14-Apr-12 Global Pharma Tenders - Weekly Alerts: April 14, 2012

6 16-Apr-12 All India Rates (AIR) of Duty Drawback for the year 2012-13

7 19-Apr-12 Promote your products in South Africa

8 21-Apr-12 Award of promotions to some officers of Pharmexcil


10 23-Apr-12 Award of promotions to some officers of Pharmexcil

11 24-Apr-12 Attention: IPR/Patent/R&D Departments-Availability of Orbit/Dialog Pro Patent Database at Pharmexcil offices

12 25-Apr-12 Promote your Products in CPhI - SEA

13 25-Apr-12 Interaction with DCG(I)

14 25-Apr-12 Visit of delegation led by Hon'ble Commerce, Industry, Trade and Textiles Minister, Govt. of India to Brazil in late May, 2012.


16 1-May-12 Iranian business delegation to India from 7th to 11th May, 2012 and Interactive meet on Payment Mechanism to Iran organized by FIEO- regarding.

17 2-May-12 Catalogue show in saudi arabia

18 7-May-12 Review of Scheduled Rates of Service Tax Refund

19 7-May-12 CPhI China 2012

20 7-May-12 Interactive Meeting with Dr. G.N. Singh, DCGI, at Mumbai on 26th April, 2012

21 7-May-12 Global Pharma Tenders - Weekly Alerts: May 5, 2012

22 11-May-12 EFC meeting with Consulate General of Iran on 22.05.2012


24 15-May-12 Visit of delegation led by Hon'ble Commerce, Industry, Trade and Textiles Minister, Govt. of India to Brazil (Revised dates 6th -8th June 2012)

25 16-May-12 Seminar on IPR & Regulatory Matters in Pharmaceutical Sector at Hyderabad on 23rd May, 2012 (Wednesday)-Reg

26 17-May-12 Availability of stalls in CPhI India

27 18-May-12 Submission of Drawback data for fixation of Duty Drawback Rate for the year 2012-13



29 25-May-12 India Pavilion at MEDICA 2012

30 29-May-12 Promote Your Products in CPhI China 2012

31 30-May-12 India Show/ Participation in CPhI Worldwide, 9-11 October 2012

32 30-May-12 India Show/ Participation in CPhI Worldwide, 9-11 October 2012, Feria De Madrid, Spainand Launch of Brand Pharma India

33 31-May-12 Seminar on Service Tax On 8.6.2012 at Mumbai

34 6-Jun-12 Postponement of Post Budget Seminar scheduled for 8th June 2012 at Mumbai with CBCE

35 7-Jun-12 Interactive Meeting with High Commissioner Designate to Tanzania 22nd June 2012, Mumbai

36 13-Jun-12 Utilization of Re-credited 4% CVD(SAD) Last Date 30.6.2012

37 14-Jun-12 Seminar on IPR & Regulatory Matters in Pharmaceutical Sector at Mumbai on 22nd June, 2012 (Friday)-Reg.

38 15-Jun-12 Interactive Meeting with Drugs Controller General (India) on 19th of June 2012 at Hyderabad

39 15-Jun-12 Global Pharma Tenders - Weekly Alerts: June 15, 2012

40 23-Jun-12 Use of Brand India Pharma Logo

41 28-Jun-12 All Industry Rates (AIR) of Duty Drawback for 2012-13 - Submission of data - Reg

42 29-Jun-12 Interactive Meeting with Director General, Drugs Control Administration, Andhra Pradesh, 5th July 2012

43 30-Jun-12 Expo-cum-BSM AROGYA Colombo, Sri Lanka 17-19th August 2012

44 2-Jul-12 Delegation to Tehran, Iran from 14 July to 17thJuly 2012 - Urgent Short Notice circular issued as per advise from Embassy

45 6-Jul-12 Seminar on IPR & Regulatory Matters in Pharmaceutical Sector at Ahmedabad on 26th July, 2012

46 6-Jul-12 Seminar on Opportunities & Procedures for Pharmaceuticals Export on 20th July 2012, Grand Ball Room, Best Western Royal Park, Baddi, Himachal Pradesh

47 7-Jul-12 Bio Technology Seminar & BSM at Kuala Lumpur, Malaysia on 31st October 2012

48 10-Jul-12 Be an Eligible Voter/Contestant in Councils Elections

49 10-Jul-12 Workshop on Regulatory Compliances in Japan for Pharmaceuticals at New Delhi on 26th July 2012 & Mumbai on 27th July 2012

50 10-Jul-12 Pharmexcil Awards for Outstanding Export Performance for the Year 2011-12

51 10-Jul-12 BSM/Pharma Business Delegation to Mexico, Gautemala, Panama & Costa Rica during 1st - 15th Sep 2012

52 11-Jul-12 New Guidelines on Export Credit in Foreign Currency

53 11-Jul-12 Awards for Companies who secured Patents during April 2011-March 2012

54 11-Jul-12 Pharmexcil Digest

55 13-Jul-12 Implementation of Bar-Coding on Secondary & Primary Packing of Export Consignment

56 16-Jul-12 Seminar on Opportunities & Procedures for Pharmaceuticals Export, 20th July 2012, Baddi, Himachal Pradesh


57 17-Jul-12 Open House Meet with Secretary, Department of Commerce & Director General of Foreign Trade

58 18-Jul-12 Pharmexcil updates by SMS Alerts

59 24-Jul-12 Council's proposal to participate in Global Ayurveda Congress scheduled during 14-16th Sep 2012 at Ontario, Canada

60 26-Jul-12 Participate in Exclusive Expo-Cum-BSM at Arogya, Srilanka

61 2-Aug-12 Block Your Diary Join Annual Celebrations of Council 26-28th Sep 2012 at Hyderabad

62 3-Aug-12 India Show / Participation at CPhI Worldwide 9-11 Oct 2012 Madrid, Spain

63 7-Aug-12 Pre-Budget Proposals for 2013-14

64 7-Aug-12 Promote your EXPORTS & INVESTMENT OPPORTUNITIES in SriLanka

65 10-Aug-12 Seminar on IPR & Regulatory Matters in Pharmaceutical Sector at Chennai on 24th August, 2012 (Friday)

66 13-Aug-12 India-Asia-Pacific International Pharma Business Meet at Hyderabad during 26-28th September 2012

67 13-Aug-12 Extension of Last Date for receipt of application for Pharmexcil Export & Patent Awards 2011-12

68 22-Aug-12 Seminar on Recent Changes in Service Tax on 25.8.2012, Hyderabad

69 25-Aug-12 Pharmexcil’s participation in Supply Side West: 7-8th Nov 2012

70 28-Aug-12 International Buyer Seller meet in India pavilion at CPhI World Wide (9-11th October 2012), Feria de Madrid, Spain

71 28-Aug-12 Councils participation in Supply Side West : 7-8th November 2012

72 29-Aug-12 India - Asia - Pacific - International Pharma Business Meet

73 30-Aug-12 Comments / Suggestions invited for Export Promotion of Traditional Medicines to Canada

74 3-Sep-12 Advertisement opportunities in India Show during CPhI World Wide, 9-11th October 2012

75 4-Sep-12 Orbit Patent Database to Pharmexcil Members - Free trial

76 5-Sep-12 Interactive Meeting with European Commission on 13th September 2012 at 6:00 pm at Hotel Taj Deccan, Hyderabad

77 5-Sep-12 Bio Technology Seminar and BSM at Kaula Lumpur, Malaysia on 31st October 2012

78 6-Sep-12 8th Annual General Meeting - NOTICE

79 7-Sep-12 India Asia Pacific International Pharma Business Meet - Promote Your Exports - Avail Sponsorship Opportunities

80 10-Sep-12 Road Show (IPhEX-2013) and Interactive Networking Dinner 20 Sep 2012, Majestic I, The Lalit, Mumbai

81 11-Sep-12 Rescheduling of Interactive Meeting with EU Preponed to 2:30 pm on 13th Sep 2012 at Hotel Taj Deccan, Hyderabad

82 14-Sep-12 Invitation - India Show at CPhI Wold Wide 2012

83 15-Sep-12 Extension of Date for Registration - India - Asia - Pacific - International Pharma Business Meet


84 15-Sep-12 Pharmexcil Digest - August 2012

85 18-Sep-12 Invitation - 8th Annual Meet of Pharmexcil at Hotel Marriott, Hyderabad

86 18-Sep-12 Postponement of Road Show (IPHEX-2013)

87 18-Sep-12 Important Clarification - Status of European Unions Directive requiring written confirmation by competent authority of export of APIs to Europe

88 20-Sep-12 Participation in APTEKA 2012 at MOSCOW, RUSSIA during 3rd-6th December 2012

89 5-Oct-12 BSM / Pharma Business Delegation to Russia, Moldova, Belarus and Turkmenistan during 1st Dec to 5th Dec 2012

90 12-Oct-12 Interactive Meeting with Senior Officials, Department of AYUSH and National Medicinal Plant Board

91 17-Oct-12 Drug Licenses without Brand Names - Governments latest decision

92 18-Oct-12 IPHEX 2013 - Book Your Stall in Pharmexcils First International Pharma Exhibition

93 19-Oct-12 Arab Health 2013

94 22-Oct-12 Presentation on IPHEX-2013 & Interactive Networking Dinner on 2nd & 3rd November at Ahmedabad & Mumbai

95 23-Oct-12 Invite Suggestions for Foreign Trade Policy 2013-14

96 23-Oct-12 Avail the Opportunity of Advertising in Show Catalogue of CPhI India 2012

97 25-Oct-12 Business Delegation to Vietnam, Philippines, Taiwan and Singapore from 13-26th January 2013

98 26-Oct-12 International Pharma Business Meet and Exhibition at Ahmadabad during 9th-11th January 2013 coinciding with Vibrant Gujarat 2013

99 29-Oct-12 Block Your Dates Pharmexcils International Business Meet (RBSM) in the side lines of 64th IPC during 7th-9th Dec, 2012 at Chennai

100 29-Oct-12 Pharmexcils International Buyer-Seller Meetings (9-10th December 2012) & AROGYA Exhibition from (7-10th December 2012) at 5th World Ayurveda Congress, Bhopal

101 1-Nov-12 Request for feedback on Global Tenders Information

102 2-Nov-12 Attention: IPR/Patent ‹/R&D Departments - Availability of Orbig/Dialog Pro Patent Databases at Pharmexcil Offices

103 5-Nov-12 Indian Government efforts for speedy registration of Medicines by PMDA, Japan-Inputs

104 6-Nov-12 Pharmexcil Business Delegation to Iran -17-19 December 2012

105 7-Nov-12 Issue of Drug Licenses without Brand Names - Present Status

106 9-Nov-12 Good News to Iran Exporters - ECGC Guarantee cover upto Rs. 300 crores to UCO Bank

107 9-Nov-12 International Pharma Business Meet and Exhibition at Ahmedabad during 9-11th January 2013, coincinding with Vibrant Gujarat

108 9-Nov-12 India Show at Bangladesh 3-5th December 2012

109 12-Nov-12 Issue of Drug Licenses without Brand names - Clarifications issued by Government


110 24-Nov-12 Utilize the Opportunity for International Marketing - BSM in 64th IPC at Chennai

111 26-Nov-12 Interactive Meeting with Chairman & Managing Director, Exim Bank - 30th November 2012 at Hyderabad

112 28-Nov-12 UKTI-FDCA Interactive Seminar with UK Medicines and Healthcare products Regulatory Agency (MHRA) 3rd, 5th and 7th December 2012 at Mumbai, Ahmedabad and Hyderabad

113 29-Nov-12 Opportunity for Traditional / Herbal / Nutraceutical Exporters to enter US / European Markets Jointly organized by Pharmexcil & New Hope USA

114 30-Nov-12 Buyer Seller Meet for Herbal & Ayurveda Products at 5th World Ayurveda Congress during 9-10 December 2012 at Bhopal

115 3-Dec-12 Utilize the Opportunity for displaying the products in International Pharma Business meet in 64th IPC at Chennai

116 4-Dec-12 List of WHOGMP/USFDA/MHRA/EDQM approved Indian Companies/Products

117 11-Dec-12 Workshops/Webinars for implementing barcoding as per DGFT guidelines

118 13-Dec-12 Certificate Course on IPR (Patent) Matters - Five day workshop at Hyderabad

119 17-Dec-12 Unique opportunity to meet the Importers from Africa

120 24-Dec-12 Two Day Workshop on Sales and Marketing - Analytics for Pharma Industry

121 24-Dec-12 Present Status on Bar Coding

122 26-Dec-12 Catalogue Show in UGANDA

123 29-Dec-12 Block Your Dates - Pharmexcils International Pharma Business Meet (RBSM) at Bio Asia 2013, 28-30th January 2013 at Hyderabad

124 31-Dec-12 Important Information - Bar Coding on Secondary Packing to be implemented from 1st January 2013

125 2-Jan-13 International Pharma Business Meet and Exhibition at Ahmedabad, Gujarat - 9-11th January 2013

126 12-Jan-13 Attention: API Exporters to EU-CDSCO Notified as Competent Authority in India

127 15-Jan-13 Reimbursement of Product Registration Charges Paid Abroad By Exporters

128 15-Jan-13 API Exporters to EU Draft Guidelines Prepared by DCGI

129 15-Jan-13 Expo-cum-BSM in Nigeria and Algeria

130 17-Jan-13 CPhI SEA, Jakarta, Indonesia - 20-22nd March 2013

131 22-Jan-13 First Time - India Pavilion in Egypt Pharma - Cairo, Egypt 13-15th April 2013

132 22-Jan-13 Interactive Meeting Delegation from Georgia, USA -1st February, 2013

133 23-Jan-13 Interactive Meeting on EU Directive and Networking Dinner for IPEX 2013 - 4th February at Hotel Lalit, Mumbai

134 23-Jan-13 BioAsia - International Business Meet during 28th “ 30th January, 2013, at Hyderabad

135 31-Jan-13 Important Message - Repeated - Expo/BSM in Algeria & Nigeria

136 2-Feb-13 Advertise in Show Catalogue - Expo/BSM in Algeria & Nigeria by PHARMEXCIL

137 14-Feb-13 IPHEX-2013: Overseas Visitor Mobilization


138 15-Feb-13 Visit of Serbian Buyers of Nutraceuticals / Dietary Supplements - Meeting at New Delhi on 21st February 2013

139 19-Feb-13 iPHEX 2013 - Sponsorship Opportunities

140 21-Feb-13 Interactive Dinner Meet (at 7:00 pm) with Serbian buyers of Nutraceuticals/Dietary Supplements on 21st Feb 2013 at The Hotel Crown Plaza, New Delhi

141 26-Feb-13 India Pavilion in KOREA PHARM 2013

142 2-Mar-13 India Pavilion at CPhI Japan from 24-26th April 2013

143 2-Mar-13 AYUSH Pavilion in IPHEX 2013 scheduled from 24-26 April 2013 at Bombay Exhibition Centre, Mumbai-Requesting your active participation

144 5-Mar-13 Stakeholder Consultation/Open House meet on "New Foreign Trade Policy Initiatives And Related Issues" with Addl. Secretarty, DoC & Additional Dgft at Hyderabad on 12.03.2013

145 8-Mar-13 API exporters to EU - Revised Draft guidelines prepared by DCGI-Comments Invited

146 8-Mar-13 Stakeholder Consultation / Open House meet with DGFT rescheduled for 14th March 2013 at Hyderabad

147 12-Mar-13 Interactive Meeting with Shri Rao Narender, Hon'ble Minister of Health, Govt. of Haryana and Networking Dinner, on 29th March 2013, Summit, Hotel Radission Blu Suites, Gurgaon, Haryana

148 15-Mar-13 Important - Attn: Finance / Accounts Departments - Seminar on Impact of Indirect and Direct Taxes - Budget 2013

149 15-Mar-13 India Pavilion at VITAFOODS at Geneva, Switzerland from 14-16 May 2013

150 26-Mar-13 Postponed - Interactive Meeting with Shri Rao Narender, Hon'ble Minister of Health, Govt of Haryana and Networking Dinner, on 29th March 2013, Summit, Hotel Radisson Blu Suites, Gurgaon, Haryana

151 29-Mar-13 Revised - India Pavilion at CPhI Japan from 24-26th April 2013


List of Trade Enquiries for the Year 2012-13

Sl No Date Subject

1 2-Apr-12 Trade Enquiry from Mexico

2 31-May-12 Trade Enquiry - NIGERIA

3 27-Jul-12 Trade Enquiry - Venezuela

4 5-Oct-12 Trade Enquiry - Syria

5 16-Oct-12 Trade Enquiry - Sri Lanka

6 26-Oct-12 Trade Enquiry - Sri Lanka

7 1-Dec-12 Trade Enquiry - Bogota

8 1-Dec-12 Trade Enquiry from Mexico

9 27-Dec-12 List of Shortage Medicines in Iran

10 4-Jan-13 Trade Enquiry - Colombia

11 22-Feb-13 Trade Enquiry - Srilanka

12 29-Mar-13 Trade Enquiry - Philippines


Export Award Winners

Medium

Bulk Drugs

Herbals

Merchant Exporters

Bio Pharma

Exports PerformanceAward 2012

Category of Award Company Name Company Name

Overall Performance Cipla Ltd

Large Aurobindo Pharma Limited Lupin Limited

Medium Ind-Swift Laboratories Limited Shasun Pharmaceuticals Limited

Small Laurus Labs Private Limited Anuh Pharma Ltd.

Emerging Smilax Laboratories Limited Aanjaneya Life Care Ltd.

Large Mylan Laboratories Limited Glenmark Pharmaceuticals Ltd.

Sun Pharmaceutical Wockhardt Limited

Small Gland Pharma Ltd Granules India Limited

Emerging Natco Pharma Limited Apex Laboratories Private Limited

Nectar Lifesciences Limited Olive Lifesciences Pvt Ltd.

Serum Institute of India Limited

Ayush & OmniActive Health Technologies Ltd.

Contract Reliance Lifesciences Pvt Ltd.

BDR Pharmaceuticals international Pvt Ltd.

North America Cadila Healthcare Ltd

LAC Aarti Drugs Ltd.

Europe + CIS Ranbaxy

ASIA Calyx

Africa + Middle East Ipca Laboratories ltd.

Sub - Category

Sub - Category

Gold

Gold

Gold Silver

Gold

Silver

Silver

Formulations Industries Limited

Nutraceuticals

Research

Region Awards


Patent Award Winners

Formulations

1 Biocon Limited, Bangalore

Bharat Biotech International Limited, Hyderabad (SME)

1. Platinum Award:

2. Gold Award:

Product Category S. No Name of Company

Over all 1 Suven Life Sciences Limited, Hyderabad


Biotech Products/Biotech Research/Genomics

Bulk Drugs/APIs 1 Dr. Reddy's Laboratories Limited, Hyderabad

1 Bharat Serums and Vaccines Limited, Mumbai (SME)

2 Wockhardt Limited, Mumbai

NCEs/Drug Discovery 1 Glenmark Pharmaceuticals Limited, Mumbai


2 Reliance Life Sciences Private Limited, Mumbai

1 Aurobindo Pharma Limited, Hyderabad

2 Emcure Pharmaceuticals Limited, Pune

3 Hetero Drugs Limited, Hyderabad

4 IPCA Laboratories Limited, Mumbai

Bulk Drugs/APIs 5 Lupin Limited, Mumbai

6 MSN Laboratories Limited, Hyderabad (SME)

7 Mylan Laboratories Limited, Hyderabad

8 Orchid Chemicals & Pharmaceuticals Limited, Chennai

9 Ranbaxy Laboratories Limited, New Delhi

1 Sun Pharma Advanced Research Company Limited, Mumbai

2 Venus Remedies Limited, Panchkula, Haryana (SME)

Medical Devices/ 1 Poly Medicure Limited, New Delhi (SME)Surgical/Diagnostics

3. Silver Award:

Biotech Products/Biotech Research/Genomics

1

Formulations


Herbals / ASU /Nutraceuticals

Bulk Drugs/APIs

Others

NCEs/Drug Discovery 1 Natco Pharma Limited, Hyderabad


1 Amoli Organics Private Limited, Vapi (SME)

2 Divis Laboratories Limited, Hyderabad

3 FDC Limited, Mumbai

4 Genesen Labs Limited, Mumbai (SME)

5 Ind-Swift Laboratories Limited, Mohali

6 Morepen Laboratories Limited, New Delhi

7 Symed Labs Limited, Hyderabad (SME)

Formulations 1 Mercury Laboratories Limited, Baroda (SME)

1 Advanced Enzymes Technologies Limited, Mumbai

2 Green Chem, Bangalore (SME)

3 LailaImpex, Vijayawada (SME)

4 Omniactive Health Technologies Limited, Mumbai (SME)

5 Sami Labs Limited, Bangalore

1 Astron Research Limited, Ahmedabad

2 Rubicon Research Private Limited, Mumbai (SME)

4. Certificate of Appreciation


Beneficiaries under MAI scheme - 2012-13

S.No BENEFICIARY Ministry Sanction DISBURSEMENTLetter No. Date AMOUNT IN 'Rs'

1 Supriya Life Science Ltd 15/47/2010-EP (Engg) dt:03.02.2012 241900

2 Harasha Pharma Pvt Ltd 15/47/2010-EP (Engg) dt:03.02.2012 90000

3 Alkem Laboratories Ltd 15/47/2010-EP (Engg) dt:03.02.2012 4677963

4 Troikaa Pharmaceuticals Ltd 15/47/2010-EP (Engg) dt:03.02.2012 603551

5 Kusum Healthcare Pvt Ltd 15/47/2010-EP (Engg) dt:03.02.2012 1659880

6 Promed Exports Pvt Ltd 15/47/2010-EP (Engg) dt:03.02.2012 1185791

7 Ipca Laboratories Ltd 15/47/2010-EP (Engg) dt:03.02.2012 1219110

8 Bal Pharma Limited 15/47/2010-EP (Engg) dt:03.02.2012 19264

9 Ortin Laboratories Ltd 15/47/2010-EP (Engg) dt:03.02.2012 23360

10 Aurobindo Pharma Ltd 15/47/2010-EP (Engg) dt:03.02.2012 529299

12 Biomedicare (India) Pvt Ltd 15/47/2010-EP (Engg) dt:03.02.2012 419273

13 Ajanta Pharma Limited 15/47/2010-EP (Engg) dt:03.02.2012 34,803

14 Sohan Healthcare Pvt. Ltd 15/21/2012-EP (Engg) Dt: 11.05.2012 102960

15 Biomedicare (India) Pvt. Ltd 15/21/2012-EP (Engg) Dt: 11.05.2012 45000

16 Aristo Pharmaceuticals Pvt. Ltd 15/21/2012-EP (Engg) Dt: 11.05.2012 270171

17 Ashish Life Science Pvt. Limited 15/21/2012-EP (Engg) Dt: 11.05.2012 179680

18 Sydler Remedies Pvt. Ltd 15/21/2012-EP (Engg) Dt: 11.05.2012 254430

19 Stedman Pharmaceuticals Pvt. Ltd 15/21/2012-EP (Engg) Dt: 11.05.2012 288989

20 Sirmaxo Chemicals Pvt. Ltd 15/21/2012-EP (Engg) Dt: 11.05.2012 99375

21 Makpar Exports Private Limited 15/21/2012-EP (Engg) Dt: 11.05.2012 260412

22 Blue Cross Laboratories Limited 15/21/2012-EP (Engg) Dt: 11.05.2012 26900

23 Bal Pharma Limited 15/21/2012-EP (Engg) Dt: 11.05.2012 378495

24 Wave Pharmaceuticals Limited 15/21/2012-EP (Engg) Dt: 11.05.2012 393712

25 Ind-Swift Laboratories Ltd 15/21/2012-EP (Engg) Dt: 11.05.2012 136127

26 Blue Cross Laboratories Limited 15/21/2012-EP (Engg) Dt: 11.05.2012 22829

27 Virchow Healthcare Private Limited 15/21/2012-EP (Engg) Dt:17.07.2012 237719

28 Apoorv International 15/21/2012-EP (Engg) Dt:17.07.2012 14822

29 Ashish Life Science Pvt. Limited 15/21/2012-EP (Engg) Dt:17.07.2012 420381

30 Jmb Pharmaceuticals 15/21/2012-EP (Engg) Dt:17.07.2012 188622

31 Glenmark Generics Limited 15/21/2012-EP (Engg) Dt:17.07.2012 122405

32 Centaur Pharmaceuticals Pvt. Ltd 15/21/2012-EP (Engg) Dt:17.07.2012 182245

33 Vexta Laboratories Pvt. Ltd 15/21/2012-EP (Engg) Dt:17.07.2012 231270

34 Aanjaneya Lifecare Ltd 15/21/2012-EP (Engg) Dt:17.07.2012 189071


35 Biomedicare (India) Pvt. Ltd 15/21/2012-EP (Engg) Dt:17.07.2012 326136

36 Shrey Nutraceuticals & 15/21/2012-EP (Engg) Dt:17.07.2012 78039Herbals Pvt. Ltd

37 Ameda Pharma Pvt. Ltd 15/21/2012-EP (Engg) Dt:17.07.2012 230422

38 Biocon Limited 15/21/2012-EP (Engg) Dt:17.07.2012 18841

39 Stedmon Pharmaceuticals 15/21/2012-EP (Engg) Dt:17.07.2012 148068Private Ltd

40 Mediwin Pharmaceuticals 15/21/2012-EP (Engg) Dt:17.07.2012 124051

41 Sg Pharma Pvt. Ltd 15/21/2012-EP (Engg) Dt:17.07.2012 160454

42 Troikaa Pharmaceuticals Ltd 15/21/2012-EP (Engg) Dt:17.07.2012 291595

43 Alembic Pharmaceuticals Limited 15/21/2012-EP (Engg) Dt:17.07.2012 105583

44 Centaur Pharmaceuticals Pvt. Ltd 15/21/2012-EP (Engg) Dt:17.07.2012 51159

45 Sr Medicare Pvt. Ltd. 15/21/2012-EP (Engg) Dt:17.07.2012 1155627

46 Macleods Pharmaceuticals Ltd 15/21/2012-EP (Engg) Dt:17.07.2012 3394303

47 Bioplus Life Sciences Pvt Ltd 15/21/2012-EP (Engg) Dt:17.07.2012 620162

48 Jodas Expoim Pvt Ltd 15/21/2012-EP (Engg) Dt:17.07.2012 2760365

49 Oxford Laboratories Pvt. Ltd 15/21/2012-EP (Engg) Dt:17.07.2012 631096

50 Protech Biosystems Pvt. Ltd 15/21/2012-EP (Engg) Dt:17.07.2012 587815

51 Fourrts (India) 15/21/2012-EP (Engg) Dt:17.07.2012 432345Laboratories Pvt. Ltd

52 Mylan Laboratories Ltd 15/21/2012-EP (Engg) Dt:17.07.2012 2189395

53 Torrent Pharmaceuticals Ltd 15/21/2012-EP (Engg) Dt:17.07.2012 1090631

54 Promed Exports Private Ltd 15/21/2012-EP (Engg) Dt:17.07.2012 174712

55 Ind-Swift Limited 15/21/2012-EP (Engg) Dt:17.07.2012 81324

56 Ind-Swift Laboratories Ltd 15/21/2012-EP (Engg) Dt:17.07.2012 98035

57 Nakoda Chemicals Ltd 15/21/2012-EP (Engg) Dt:17.07.2012 45525

58 Nutra Specialities Private Limited 15/21/2012-EP (Engg) Dt:17.07.2012 80000

59 J.B. Chemicals & Pharmaceuticals Ltd 15/21/2012-EP (Engg) Dt:19.11.2012 450078

60 Makpar Exports Private Limited 15/21/2012-EP (Engg) Dt:19.11.2012 201750

61 Macleods Pharmaceuticals Ltd 15/21/2012-EP (Engg) Dt:19.11.2012 54285

62 Rainbow Life Sciences Pvt Ltd 15/21/2012-EP (Engg) Dt:19.11.2012 297397

63 Agio Pharmaceuticals Limited 15/21/2012-EP (Engg) Dt:19.11.2012 2162256

64 Fredun Pharmaceuticals Limited 15/21/2012-EP (Engg) Dt:19.11.2012 101093

65 Oxford Laboratories Pvt. Ltd. 15/21/2012-EP (Engg) Dt:19.11.2012 65190

66 Ind-Swift Limited 15/21/2012-EP (Engg) Dt:19.11.2012 52191

67 Polymedicure Ltd 15/21/2012-EP (Engg) Dt:19.11.2012 259541

68 Nosch Labs Private Limited 15/21/2012-EP (Engg) Dt:19.11.2012 138822


69 Indian Herbs Research & 15/21/2012-EP (Engg) Dt:19.11.2012 346117Supply Co. Ltd

70 Troikaa Pharmaceuticals Limited 15/21/2012 - EP (Engg) dt:19.11.2012 45353

71 Karan Heatlhcare (P) Ltd 15/21/2012-EP (Engg) Dt:17.07.2012 862557

72 Hetero Labs Limited 15/21/2012 - EP (Engg) dt:19.11.2012 77334

73 Alembic Pharmaceuticals Limited 15/21/2012 - EP (Engg) dt:19.11.2012 247327

74 J.B. Chemicals & 15/21/2012-EP (Engg) Dt:17.07.2012 197960Pharmaceuticals Ltd

TOTAL 35184743


S.No. Company Name Event Name Amount

1 Akriti Pharmaceuticals Pvt Ltd 15th South East Asian Healthcare & Pharma Exhibition, Malaysia17th -19th April 2012 Exhibition, Malaysia17th -19th April 2012 125600

2 Coral Laboratories Ltd 15th South East Asian Healthcare & Pharma Exhibition, Malaysia 17th -19th April 2012 150000

3 Dhathri Ayurveda Pvt Ltd 15th South East Asian Healthcare & Pharma Exhibition, Malaysia 17th -19th April 2012 128100

4 Dr.Smita's Herbal Laboratories 15th South East Asian Healthcare & Pharma Exhibition, Malaysia 17th -19th April 2012 150000

5 Finecure Pharmaceuticals Ltd 15th South East Asian Healthcare & Pharma Exhibition, Malaysia 17th -19th April 2012 150000

6 Innovative Tastant 15th South East Asian Healthcare & Technologies Pvt Ltd Pharma Exhibition, Malaysia

17th -19th April 2012 150000

7 Jayon Implants Pvt Ltd 15th South East Asian Healthcare & Pharma Exhibition, Malaysia 17th -19th April 2012 150000

8 Labhi Pharmaceuticals 15th South East Asian Healthcare & Pharma Exhibition, Malaysia 17th -19th April 2012 113525

9 Lemak International 15th South East Asian Healthcare & Pharma Exhibition, Malaysia 17th -19th April 2012 150000

10 Meridian Enterprises Pvt Ltd 15th South East Asian Healthcare & Pharma Exhibition, Malaysia 17th -19th April 2012 75792

11 Ocean Pharmacoat Pvt Ltd 15th South East Asian Healthcare & Pharma Exhibition, Malaysia 17th -19th April 2012 150000

12 Pell Tech Heatlhcare Pvt Ltd 15th South East Asian Healthcare & Pharma Exhibition, Malaysia 17th -19th April 2012 109260

13 Rasino Herbs Pvt Ltd 15th South East Asian Healthcare & Pharma Exhibition, Malaysia 17th -19th April 2012 75837

14 Sunil Heatlhcare Ltd 15th South East Asian Healthcare & Pharma Exhibition, Malaysia 17th -19th April 2012 150000

Beneficiaries under MDA scheme - 2012-13


15 Tunic Health Care 15th South East Asian Healthcare & Pharma Exhibition, Malaysia 17th -19th April 2012 125814

16 Vaipani Herbal 15th South East Asian Healthcare & Pharma Exhibition, Malaysia 17th -19th April 2012 126584

17 Yashica Pharmaceuticals Pvt Ltd Africa Health, South Africa 9-11th May 2012 150000

18 Gujarat Healthcare Africa Health, South Africa 9-11th May 2012 128094

19 The Cottron Products of India Africa Health, South Africa 9-11th May 2012 124262

20 Micromaster Labs Pvt Ltd Africa Health, South Africa 9-11th May 2012 150000

21 Udaipur Surgicals Pvt Ltd Africa Health, South Africa 9-11th May 2012 124262

22 Pharm Products Pvt Ltd Africa Health, South Africa 9-11th May 2012 130530

23 Mediwin Pharmaceuticals Africa Health, South Africa 9-11th May 2012 150000

24 Grace Drugs & Pharmaceuticals Africa Health, South Africa 9-11th May 2012 150000

25 Nej Biotech Africa Health, South Africa 9-11th May 2012 150000

26 Intermed Africa Health, South Africa 9-11th May 2012 150000

27 Lamar Exports Pvt Ltd Africa Health, South Africa 9-11th May 2012 150000

28 West Bengal Chemical Industries Africa Health, South Africa 9-11th May 2012 150000

29 Akhil Healthcare Pvt Ltd CPHI South East Asia 10th -12th May 2012, Jakarta Indonesia 1238910

30 Anuja Healthcare Pvt Ltd CPHI South East Asia 10th -12th May 2012, Jakarta Indonesia 150000

31 ASG Biochem Pvt Ltd CPHI South East Asia 10th -12th May 2012, Jakarta Indonesia 150000

32 BCM Corporation CPHI South East Asia 10th -12th May 2012, Jakarta Indonesia 150000

33 DPB Antibiotics CPHI South East Asia 10th -12th May 2012, Jakarta Indonesia 150000

34 Everest Organics Ltd CPHI South East Asia 10th -12th May 2012, Jakarta Indonesia 150000

35 Kopalle Pharma Chemicals Pvt Ltd CPHI South East Asia 10th -12th May 2012, Jakarta Indonesia 150000


36 Labela Regsources Pvt Ltd CPHI South East Asia 10th -12th May 2012, Jakarta Indonesia 150000

37 Leamak International CPHI South East Asia 10th -12th May 2012, Jakarta Indonesia 150000

38 Macsen Laboratories CPHI South East Asia 10th -12th May 2012, Jakarta Indonesia 136035

39 Mars Therapeutics & Chemicals Limited CPHI South East Asia 10th -12th May 2012, Jakarta Indonesia 110342

40 Meridian Enterprises Pvt Ltd CPHI South East Asia 10th -12th May 2012, Jakarta Indonesia 106839

41 Ocean Pharmacoat Pvt Ltd CPHI South East Asia 10th -12th May 2012, Jakarta Indonesia 150000

42 Piramal Life Sciences Limited CPHI South East Asia 10th -12th May 2012, Jakarta Indonesia 150000

43 Qualiteck Pharma CPHI South East Asia 10th -12th May 2012, Jakarta Indonesia 107712

44 Redline Healthcare CPHI South East Asia 10th -12th May 2012, Jakarta Indonesia 109500

45 RioCare India Private Limited CPHI South East Asia 10th -12th May 2012, Jakarta Indonesia 116738

46 Shreeji Pharma International CPHI South East Asia 10th -12th May 2012, Jakarta Indonesia 116738

47 Shruti Drugs Pvt Ltd CPHI South East Asia 10th -12th May 2012, Jakarta Indonesia 150000

48 Solitaire Pharmacia Pvt Ltd CPHI South East Asia 10th -12th May 2012, Jakarta Indonesia 150000

49 Spansules Pharmatech Pvt Ltd CPHI South East Asia 10th -12th May 2012, Jakarta Indonesia 150000

50 Supreem Pharmaceuticals CPHI South East Asia 10th -12th Mysore Pvt Ltd May 2012, Jakarta Indonesia 150000

51 Swati Spentose Pvt Ltd CPHI South East Asia 10th -12th May 2012, Jakarta Indonesia 150000

52 Swiss Pharma Pvt Ltd CPHI South East Asia 10th -12th May 2012, Jakarta Indonesia 150000

53 Neelam Phyto -Extracts Vita Foods - 2012, Geneva, Switzerland - 22nd to 24th May 2012. 80000

54 Aaisland Chemicasl Products Vita Foods - 2012, Geneva, Switzerland - 22nd to 24th May 2012. 80000

55 Bio-Gen Extracts Pvt. Ltd Vita Foods - 2012, Geneva, Switzerland - 22nd to 24th May 2012. 80000

56 Venkatesh Food Industries Vita Foods - 2012, Geneva, Switzerland - 22nd to 24th May 2012. 80000

57 Drugs India Vita Foods - 2012, Geneva, Switzerland - 22nd to 24th May 2012. 80000


58 Healthcaps India Ltd CPhI China, 2012 SNIEC, Shanghai, China 26-28 June, 2012 80000

59 Innovative Tastant CPhI China, 2012 SNIEC, Technologies Pvt Ltd Shanghai, China 26-28 June, 2012 80000

60 Akriti Pharmaceuticals Pvt. Ltd Delegation to Mexico, Guatemala, Panama & Costa Rica from 1st 50 5th September 2012 100000

61 Apex Drug House Delegation to Mexico, Guatemala, Panama & Costa Rica from 1st 50 5th September 2012 100000

62 Makcur Laboratoreis Ltd Delegation to Mexico, Guatemala, Panama & Costa Rica from 1st 50 5th September 2012 100000

63 Mediwin Pharmaceuticals Delegation to Mexico, Guatemala, Panama & Costa Rica from 1st 50 5th September 2012 100000

64 Natural Capsules Ltd Delegation to Mexico, Guatemala, Panama & Costa Rica from 1st 50 5th September 2012 100000

65 Nem Laboratories Ltd Delegation to Mexico, Guatemala, Panama & Costa Rica from 1st 50 5th September 2012 100000

66 Pharma Chemico Laboratories Delegation to Mexico, Guatemala, Panama & Costa Rica from 1st 50 5th September 2012 100000

67 R.S. Bhargava Pharmacy Delegation to Mexico, Guatemala, Panama & Costa Rica from 1st 50 5th September 2012 100000

68 Redline Healthcare Delegation to Mexico, Guatemala, (Associate of Pharmchem) Panama & Costa Rica from 1st 50 5th

September 2012 100000

69 Rhydburg Pharmaceuticals Ltd Delegation to Mexico, Guatemala, Panama & Costa Rica from 1st 50 5th September 2012 100000

70 Saga Laboratories Delegation to Mexico, Guatemala, Panama & Costa Rica from 1st 50 5th September 2012 100000

71 Sance Laboratories Pvt. Ltd Delegation to Mexico, Guatemala, Panama & Costa Rica from 1st 50 5th September 2012 100000

72 SG Pharma Pvt. Ltd Delegation to Mexico, Guatemala, Panama & Costa Rica from 1st 50 5th September 2012 100000

73 Shree Ganesh Pharmaceuticals Delegation to Mexico, Guatemala, Panama & Costa Rica from 1st 50 5th September 2012 100000


74 Siddharth International Supply Side West - 2012, Las Vegas, USA 7-8th November 2012 80000

75 Shree Ambika Naturals Pvt. Ltd Supply Side West - 2012, Las Vegas, USA 7-8th November 2012 80000

76 Supreem Pharmaceuticals Supply Side West - 2012, Las Vegas, Mysore Pvt. Ltd USA 7-8th November 2012 80000

77 Herbs India Supply Side West - 2012, Las Vegas, USA 7-8th November 2012 80000

78 Cultivator Natural Products Supply Side West - 2012, Las Vegas, USA 7-8th November 2012 80000

79 Pharmachemico Laboratories APTEKA Moscow, Russia held from 3rd to 6th December 2012 131222

80 Virupaksha Laboratories Pvt. Ltd APTEKA Moscow, Russia held from 3rd to 6th December 2012 150000

81 Curemed Healthcare Pvt. Ltd APTEKA Moscow, Russia held from 3rd to 6th December 2012 150000

82 Brassica Pharma Pvt. Ltd APTEKA Moscow, Russia held from 3rd to 6th December 2012 109799

83 Clearsynth Labs (P) Ltd APTEKA Moscow, Russia held from 3rd to 6th December 2012 107000

84 Gujarat Healthcare APTEKA Moscow, Russia held from 3rd to 6th December 2012 119950

85 Natural Capsules Ltd APTEKA Moscow, Russia held from 3rd to 6th December 2012 104027

86 Oasis Laboratories Pvt. Ltd APTEKA Moscow, Russia held from 3rd to 6th December 2012 113500

87 S L Drugs & Pharmaceuticals APTEKA Moscow, Russia held from 3rd to 6th December 2012 87691

88 Nej biotec APTEKA Moscow, Russia held from 3rd to 6th December 2012 108108

89 Shreeji Pharma International APTEKA Moscow, Russia held from 3rd to 6th December 2012 101816

90 Akriti Pharmaceuticals Pvt. Ltd Delegation to Russia, Moldova, Belarus & Turkmenistan 1st Dec to 15th Dec 2012 38069

91 Leamak International Delegation to Russia, Moldova, Belarus & Turkmenistan 1st Dec to 15th Dec 2012 70000

92 Mediwin Pharmaceuticals Delegation to Russia, Moldova, Belarus & Turkmenistan 1st Dec to 15th Dec 2012 70000

93 Nem Laboratories Pvt Ltd Delegation to Russia, Moldova, Belarus & Turkmenistan 1st Dec to 15th Dec 2012 70000

94 Roerich Healthcare Delegation to Russia, Moldova, Belarus & Turkmenistan 1st Dec to 15th Dec 2012 60009

95 Shayana Healthcare Pvt. Ltd Delegation to Russia, Moldova, Belarus & Turkmenistan 1st Dec to 15th Dec 2012 70000


96 Theon Pharmaceuticals Ltd Delegation to Russia, Moldova, Belarus & Turkmenistan 1st Dec to 15th Dec 2012 70000

97 Stericat Gutstrings Pvt. Ltd MEDICA – 2012, Dusseldorf, Germany 14th -17th November 2012 80000

98 Udaipur Healthcare Pvt. Ltd MEDICA – 2012, Dusseldorf, Germany 14th -17th November 2012 80000

99 Titan Biotech Limited MEDICA – 2012, Dusseldorf, Germany 14th -17th November 2012 80000

100 Makcur Laboratories Ltd Delegation to Russia, Moldova, Belarus & Turkmenistan 1st Dec to 15th Dec 2012 70000

101 Meenaxy Pharma Pvt. Ltd Delegation to Russia, Moldova, Belarus & Turkmenistan 1st Dec to 15th Dec 2012 70000

102 Riocare India Pvt. Ltd Delegation to Russia, Moldova, Belarus & Turkmenistan 1st Dec to 15th Dec 2012 70000

103 sance Laboratories Pvt. Ltd Delegation to Russia, Moldova, Belarus & Turkmenistan 1st Dec to 15th Dec 2012 70000

104 Blue Neem Medical Devices Pvt. Ltd MEDICA – 2012, Dusseldorf, Germany 14th -17th November 2012 72000

105 Bio-Rad Medisys Pvt. Ltd MEDICA – 2012, Dusseldorf, Germany 14th -17th November 2012 80000

106 Ishwari Healthcare Pvt. Ltd MEDICA – 2012, Dusseldorf, Germany 14th -17th November 2012 72000

107 Pharma Chemico Laboratories Delegation to Russia, Moldova, Belarus & Turkmenistan 1st Dec to 15th Dec 2012 63000

108 Labdhi Pharmaceuticals Delegation to Russia, Moldova, Belarus & Turkmenistan 1st Dec to 15th Dec 2012 63000

TOTAL 13191665

Interactive Meeting with Drugs Controller General (India), Hyderabad - 19th June 2012

Interactive Meeting with Drugs Controller General (India), Hyderabad - 19th June 2012

Interactive Meeting with High Commissioner Designate to Tanzania at Mumbai - 22nd June 2012

Seminar on IPR & Regulatory Matters, Hyderabad – 23rd May 2012

Seminar on IPR & Regulatory Matters, Hyderabad – 23rd May 2012

India Pavilion and Pharma Brand India Campaign at CPhI-SEA Indonesia 10-12th May 2012

India Pavilion at CPhI China, Shangai, China - 26-28th June 2012

India Pavilion at CPhI China, Shangai, China - 26-28th June 2012

Regd. / Head Office :

101, Aditya Trade Center,

Ameerpet, Hyderabad – 500 016.

Ph: 91-40-23735462/66

Fax: 91-4027375464

E-mail: [email protected]

Branch Office - Ahmedabad :

7-C, Trade Centre, Near Stadium Cross Road,

Navarangpura, Ahmedabad – 380 009.

Ph: 91-79-40050497


Regional Office - Mumbai :

TV Industrial Estate, Unit No. 211, 2nd Floor, 248-

A S.K. Ahire Marg, Worli, Mumbai - 400 030.

Ph: 91-22-24938750/51/58/59

Fax: 91-22-24938822


Regional Office - New Delhi :

305, Padma Tower II, 22, Rajendra Palace,

New Delhi – 110 008.

Ph: 91-11-41536654 / 45062550

Fax: 91-11-41536658


Website: www.pharmexcil.com

Pharmaceuticals Export Promotion Council of India

Documents

Annual Report 23-9-13